U.S. patent application number 14/848880 was filed with the patent office on 2017-03-09 for dispensers for microcapsules.
The applicant listed for this patent is The Procter & Gamble Company. Invention is credited to Lee BURROWES, William John Cleveland CONNOLLY, Alex Didier MILIAN, Yannick Jacques POINTEL.
Application Number | 20170065996 14/848880 |
Document ID | / |
Family ID | 58056509 |
Filed Date | 2017-03-09 |
United States Patent
Application |
20170065996 |
Kind Code |
A1 |
BURROWES; Lee ; et
al. |
March 9, 2017 |
Dispensers For Microcapsules
Abstract
A dual dispenser having two pumps associated with a first and
second receptacle and a common dispenser head, said common
dispenser head having an output forming a dispensing orifice, said
output channel being fed with the fluid products coming out of the
two pumps, such that the two pumps have actuating rods that are
movable axially over travel paths of different lengths, i.e. a
first actuating rod having a long travel path and a second
actuating rod having a short travel path; the common dispenser head
has a pivoting member which forms two support elements for
simultaneously moving the two actuating rods over an axial height
corresponding to the short travel path, the support elements then
continuing their movements by pivoting/rotation of the pivoting
member to finish the long travel path; wherein the first receptacle
contains a first composition, the first composition including a
volatile solvent and a first fragrance; wherein the second
receptacle contains a second composition, the second composition
including a carrier and a plurality of microcapsules; and methods
relating thereto.
Inventors: |
BURROWES; Lee; (Horsell,
GB) ; CONNOLLY; William John Cleveland; (Windlesham,
GB) ; MILIAN; Alex Didier; (Les Baux de Breteuil,
FR) ; POINTEL; Yannick Jacques; (Epegard,
FR) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
The Procter & Gamble Company |
Cincinnati |
OH |
US |
|
|
Family ID: |
58056509 |
Appl. No.: |
14/848880 |
Filed: |
September 9, 2015 |
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61L 9/14 20130101; B05B
15/55 20180201; B05B 11/3084 20130101 |
International
Class: |
B05B 11/00 20060101
B05B011/00; A61L 9/14 20060101 A61L009/14 |
Claims
1. A dual dispenser comprising a first pump in liquid communication
with a first receptacle, a second pump in liquid communication with
a second receptacle, and a common dispenser head, said common
dispenser head comprising an output channel forming a dispensing
orifice, said output channel being fed with a first and second
composition coming out of the first and second pumps; wherein the
first pump is operatively associated with a first actuating rod and
the second pump is operatively associated with a second actuating
rod; wherein the first actuating rod has a longer travel path than
the second actuating rod; wherein the common dispenser head
comprises a pivoting member which forms two support elements for
simultaneously moving the two actuating rods over an axial height
corresponding to the shorter travel path, the support elements then
continuing their movements by pivoting/rotation of the pivoting
member to finish the longer travel path; wherein the first
receptacle comprises the first composition, the first composition
comprising a volatile solvent and a first fragrance; wherein the
second receptacle comprises the second composition, the second
composition comprising a carrier and a plurality of
microcapsules.
2. The dual dispenser of claim 1, wherein the two support elements
are integral with each other in movement.
3. The dual dispenser of claim 1, wherein the two support elements
are integral with the output channel.
4. The dual dispenser of claim 1, wherein the two support elements
extend on either side of the output channel, advantageously
symmetrically.
5. The dual dispenser of claim 1, wherein the two support elements
pivot around the output channel.
6. The dual dispenser of claim 1, wherein the pivoting member
comprises at least one thrust transmission zone, so that an axial
thrust exerted on said thrust transmission zone first causes the
translatory movement of the two support elements and of the output
channel over the shorter travel path, then a slight rotation of the
output channel around its own axis and the pivoting of the support
elements to finish the longer travel path.
7. The dual dispenser of claim 6, wherein the common dispenser head
comprises a cover which comes in supporting contact on the thrust
transmission zones.
8. The dual dispenser of claim 7, wherein the output channel
comprises a thrust transmission zone near each of the ends
thereof.
9. The dual dispenser of claim 8, wherein the support elements
extend substantially perpendicular to the output channel between
the two thrust transmission zones.
10. The dual dispenser of claim 1, wherein the first actuating rod
having the longer travel path is connected to the output channel
closer to the dispensing orifice than the second actuating rod
having the shorter travel path.
11. The dual dispenser of claim 1, wherein each actuating rod is
topped by a cap defining a support plate for the respective support
element thereof, and a connector fitting receiving a flexible
conduit which connects the output channel.
12. The dual dispenser of claim 1, wherein the plurality of
microcapsules encapsulate a second fragrance.
13. The dual dispenser of claim 1, wherein the microcapsules
comprise a shell comprising a material selected from the group
consisting of polyacrylates; polyethylenes; polyamides;
polystyrenes; polyisoprenes; polycarbonates; polyesters; polyureas;
polyurethanes; polyolefins; polysaccharides; epoxy resins; vinyl
polymers; urea cross-linked with formaldehyde or gluteraldehyde;
melamine cross-linked with formaldehyde; gelatin-polyphosphate
coacervates optionally cross-linked with gluteraldehyde;
gelatin-gum Arabic coacervates; cross-linked silicone fluids;
polyamine reacted with polyisocyanates; acrylate monomers
polymerized via free radical polymerization; silk; wool; gelatine;
cellulose; proteins; and combinations thereof.
14. The dual dispenser of claim 13, wherein the microcapsules
comprise a polyacrylate shell.
15. The dual dispenser of claim 1, wherein the microcapsules have a
median volume-weighted particle size of from 2 microns to 80
microns, preferably from 10 microns to 30 microns, more preferably
from 10 microns to 20 microns.
16. The dual dispenser of claim 1, wherein the volatile solvent
comprises ethanol.
17. The dual dispenser of claim 16, wherein the first composition
comprises 0.01% to 98%, by weight, of ethanol.
18. The dual dispenser of claim 1, wherein the carrier comprises
water.
19. The dual dispenser of claim 18, wherein the second composition
comprises from 5% to 95%, by weight, of water.
20. The dual dispenser of claim 1, wherein at least one of the
compositions is free of a propellant.
21. The dual dispenser of claim 1, wherein at least one of the
compositions further comprises a coloring agent.
22. The dual dispenser of claim 1, wherein the second composition
further comprises a suspending agent.
23. The dual dispenser of claim 1, wherein the second composition
further comprises from 5% to 90%, of a cross-linked polyacrylate
polymer.
24. The dual dispenser of claim 1, wherein the second composition
is substantially free of a material selected from the group
consisting of a propellant, ethanol, a detersive surfactant, and
combinations thereof; preferably free of a material selected from
the group consisting of a propellant, ethanol, a detersive
surfactant, and combinations thereof.
25. The dual dispenser of claim 1, wherein the first composition is
substantially free of a material selected from the group consisting
of a propellant, microcapsules, a detersive surfactant, and
combinations thereof; preferably free of a material selected from
the group consisting of propellant, microcapsules, a detersive
surfactant, and combinations thereof.
26. The dual dispenser of claim 1, wherein the carrier is water and
the second composition comprises from about 0.1% to about 95% by
weight of the second composition of the water.
27. A method of providing a longer lasting fragrance, the method
comprising spraying the first and second composition using the dual
dispenser of claim 1.
Description
TECHNICAL FIELD
[0001] The present disclosure generally relates to dispensers
capable of dispensing microcapsules.
BACKGROUND
[0002] Consumers often desire to deliver pleasant fragrances during
and/or after application of a product. Such fragrances often
contain perfume oils and/or other odoriferous materials that
provide a scent for a limited period of time. It is also not
uncommon to include a solvent for solubilizing the perfumes oils
and/or other odoriferous materials. At times, such solvents may be
incompatible with other ingredients that may provide a benefit to
the consumer. While dispensers that contain separate chambers for
separating incompatible ingredients may exist, such dispensers may
not provide a consistent experience to the consumer or may not be
capable of dispensing certain ingredients without damaging and/or
clogging the system. Thus, there exists a need for dispensers than
can keep some incompatible ingredients separate while delivering a
consistent experience to the consumer.
SUMMARY
[0003] A dual dispenser comprising a first pump (P1) in liquid
communication with a first receptacle (R1), a second pump (P2) in
liquid communication with a second receptacle (R2), and a common
dispenser head, said common dispenser head comprising an output
channel (10) forming a dispensing orifice (14), said output channel
(10) being fed with a first and second composition coming out of
the first and second pumps (P1, P2); wherein the first pump (P1) is
operatively associated with a first actuating rod (P11) and the
second pump (P2) is operatively associated with a second actuating
rod (P21); wherein the first actuating rod (P11) has a longer
travel path than the second actuating rod (P21); wherein the common
dispenser head comprises a pivoting member (1) which forms two
support elements (1C1, 1C2) for simultaneously moving the two
actuating rods (P11, P21) over an axial height corresponding to the
shorter travel path, the support elements (1C1, 1C2) then
continuing their movements by pivoting/rotation of the pivoting
member (1) to finish the longer travel path; wherein the first
receptacle (R1) comprises the first composition, the first
composition comprising a volatile solvent and a first fragrance;
wherein the second receptacle (R2) comprises the second
composition, the second composition comprising a carrier and a
plurality of microcapsules.
[0004] A method of providing a longer lasting fragrance, the method
comprising spraying the first and second composition using the
aforementioned dual dispenser.
BRIEF DESCRIPTION OF THE DRAWINGS
[0005] While the specification concludes with claims, it is
believed that the same will be better understood from the following
description taken in conjunction with the accompanying drawings in
which:
[0006] FIG. 1 is an exploded view in perspective of a dispenser
disclosed herein, the two receptacles not being represented,
[0007] FIG. 2 is a view in vertical cross-section through the
dispenser of FIG. 1 in the assembled state and resting position, in
the absence of receptacles,
[0008] FIG. 3 is a cutaway top view of FIG. 2;
[0009] FIG. 4 is a view similar to the one in FIG. 2, with the
dispenser head having completed the short travel path, and
[0010] FIG. 5 is a view similar to the one in FIG. 4, with the
dispenser head having completed the long travel path.
[0011] FIG. 6 is a front view of a pair of receptacles containing a
first and second composition.
[0012] FIGS. 1 to 3 will be referred to independently in order to
describe in detail the structure of a dual dispenser according to
the invention capable of dispensing simultaneously two fluid
products of different natures, textures and/or properties. An
optional shell containing the two receptacles is also not
represented.
DETAILED DESCRIPTION
[0013] All percentages are weight percentages based on the weight
of the composition, unless otherwise specified. All ratios are
weight ratios, unless specifically stated otherwise. All numeric
ranges are inclusive of narrower ranges; delineated upper and lower
range limits are interchangeable to create further ranges not
explicitly delineated. The number of significant digits conveys
neither limitation on the indicated amounts nor on the accuracy of
the measurements. All measurements are understood to be made at
about 25.degree. C. and at ambient conditions, where "ambient
conditions" means conditions under about one atmosphere of pressure
and at about 50% relative humidity.
[0014] "Composition" as used herein, means ingredients suitable for
topical application on mammalian keratinous tissue. Such
compositions may also be suitable for application to textiles or
any other form of clothing including, but not limited to, clothing
made from synthetic fibers like nylons and polyesters, and clothing
made from acetate, bamboo, cupro, hemp, flannel, jute, lyocell,
PVC-polyvinyl chloride, rayon, recycled materials, rubber, soy,
Tyvek, cotton, and other natural fibers.
[0015] "Free of" means that the stated ingredient has not been
added to the composition. However, the stated ingredient may
incidentally form as a byproduct or a reaction product of the other
components of the composition.
[0016] "Nonvolatile" refers to those materials that liquid or solid
under ambient conditions and have a measurable vapor pressure at
25.degree. C. These materials typically have a vapor pressure of
less than about 0.0000001 mmHg, and an average boiling point
typically greater than about 250.degree. C.
[0017] "Soluble" means at least about 0.1 g of solute dissolves in
100 ml of solvent at 25.degree. C. and 1 atm of pressure.
[0018] "Substantially free of" means an amount of a material that
is less than 1%, 0.5%, 0.25%, 0.1%, 0.05%, 0.01%, or 0.001% by
weight of a composition.
[0019] "Derivatives" as used herein, include but are not limited
to, amide, ether, ester, amino, carboxyl, acetyl, and/or alcohol
derivatives of a given chemical.
[0020] "Skin care actives" as used herein, means substances that
when applied to the skin, provide a benefit or improvement to the
skin. It is to be understood that skin care actives are useful not
only for application to skin, but also to hair, nails and other
mammalian keratinous tissue.
[0021] "Situs" means the location where the composition is applied.
Non-limiting examples of a situs include mammalian keratinous
tissue and clothing.
[0022] "Volatile," as used herein, unless otherwise specified,
refers to those materials that are liquid or SOLID under ambient
conditions and which have a measurable vapor pressure at 25.degree.
C. These materials typically have a vapor pressure of greater than
about 0.0000001 mmHg, alternatively from about 0.02 mmHg to about
20 mmHg, and an average boiling point typically less than about
250.degree. C., alternatively less than about 235.degree. C.
Dispensers
[0023] The disclosure herein concerns a dual dispenser comprising
two receptacles of different fluid products, two pumps and a common
dispenser head, said common dispenser head comprising an output
channel forming an output orifice, said output channel being fed
with the fluid products from the two pumps.
[0024] Dual dispensers have long been known that are capable of
dispensing two different fluid products from distinct receptacles
through a single common dispensing orifice. Document FR2654016 is
an example thereof. It describes a dual dispenser comprising a
rotary wedge that is movable above the actuating rod of one of the
pumps to vary the insertion of the actuating rod, thus varying the
dose to be mixed with the dose dispensed by the other pump.
[0025] In contrast, the dispensers herein do not vary the dose
dispensed by the pumps by acting on the course of travel of one of
the actuating rods, but rather to dephase the dispensing of the
fluid products at the end of travel, so that only one fluid product
is dispensed through the dispensing orifice at the end of the
dispensing phase. In other words, the dispensing orifice is only in
contact with one fluid product after the dispensing phase, i.e. the
dispensing orifice is only in contact with the two fluid products
during the dispensing phases.
[0026] To achieve this end, the dispensers herein may comprise two
pumps associated respectively with two receptacles of different
fluid products and a common dispenser head, said common dispenser
head comprising an output channel forming an output orifice, said
output channel being fed with the fluid products from the two
pumps,
wherein:
[0027] the two pumps comprise actuating rods that are movable
axially over travel paths of different lengths, i.e. a first
actuating rod having a long travel path and a second actuating rod
having a short travel path,
[0028] the common dispenser head comprises a pivoting member which
forms two support elements for simultaneously moving the two
actuating rods over an axial height corresponding to the short
travel path, the support elements then continuing their movements
by pivoting/rotation of the pivoting member to terminate the long
travel path.
[0029] Thus, the two support elements first travel, from the
position of rest of the common dispenser head, over a travel path
that is identical, symmetrical and synchronous, then, when the
second actuating rod having a short travel path has been fully
inserted, the support elements begin a pivoting/rotational movement
of the pivoting member, so that the support element associated with
the first actuating rod having a long travel path follows its axial
trajectory until the first actuating rod is fully inserted. It is
preferable for the actuating forces of the two actuating rods to be
substantially or perfectly identical. Furthermore, axial guiding
means must be provided that enable an identical, symmetrical and
synchronous movement of the two support elements.
[0030] According to one advantageous characteristic, the two
support elements are integral with each other in movement.
Preferably, the two support elements are integral with the output
channel. More preferably yet, the two support elements extend on
either side of the output channel, advantageously symmetrically.
The output channel can for example be rectilinear over at least
part of its length, and the two support elements can extend
symmetrically opposite from the channel.
[0031] According to another advantageous aspect, the two support
elements pivot around the output channel. This induces a slight
rotation of the output channel around its own axis, since it
functions as a pivot axis for the two support elements.
[0032] According to another advantageous aspect, the pivoting
member can comprise at least one thrust transmission zone, and
advantageously two, so that an axial thrust exerted on said thrust
transmission zone first causes the translatory movement of the two
support elements and of the output channel over the short travel
path, and then a slight rotation of the output channel around its
own axis and the pivoting of the support elements to terminate the
long travel path. In other words, the output channel and its two
support elements are first moved translationally over the short
travel path, then they pivot around the contact point of the
support element which is stopped at the second fully inserted
actuating rod. The support element associated with the first
actuating rod continues its downward movement, not in a translatory
manner, but rather describing an arc of circle the radius of which
corresponds to the distance between the contact points of the two
support elements. The output channel also describes a slight arc of
circle, but with a smaller radius, i.e. half that of the support
elements.
[0033] According to another advantageous characteristic, the common
dispenser head comprises a cover which is in support contact on the
thrust transmission zones. Advantageously, the output channel
comprises a thrust transmission zone near each of its ends.
Advantageously, the support elements extend substantially
perpendicular to the output channel between the two thrust
transmission zones. The formation of two thrust transmission zones
makes it possible to distribute the thrust equally over the length
of the output channel, and the fact of positioning the transmission
zones at the ends of the channel makes it possible to maintain the
channel perfectly stable during the movement thereof.
[0034] According to a very interesting aspect, the first actuating
rod having the long travel path can be connected to the output
channel closer to the dispenser orifice than the second actuating
rod having the short travel path. Thus, the fluid product coming
out of the first actuating rod (having a long travel path) will
pass alone and last through the dispenser orifice during each
dispensing phase, so that in the rest position, there is only fluid
product coming out of the first actuating rod at the dispenser
orifice. This is particularly advantageous when the fluid product
coming out of the second actuating rod is sensitive, or can become
denatured or can deteriorate in contact with air. By using a fluid
product (coming out of the first actuating rod) that is more stable
and/or with disinfecting or bactericidal properties, it is ensured
that there will be no contaminated or altered residue of fluid
product at the dispenser orifice.
[0035] In some examples, each actuating rod can be topped by a cap
defining a support plate for its respective support element and a
connector fitting receiving a flexible conduit which connects to
the output channel. Said cap can simply be force fit onto the free
end of the actuating rod.
[0036] The design of the dispensers disclosed herein rests on the
principle of actuating both pumps by means of a rotational member
which is moved first translationally over the path common to both
pumps, then by rotation or pivoting to terminate the actuation of
the pump which has the longest travel path. Thus, one of the pumps
will dispense the fluid product after the other pump at the end of
the dispensing phase in order to expose the dispensing orifice, and
a section of the output channel, only to one fluid product, which
will advantageously have stable, disinfecting and/or bactericidal
properties.
[0037] Thus, the dual dispensers disclosed herein comprises two
pumps P1 and P2 each comprising a pump body P10 and P20 as well as
two actuating rods P11 and P21 which are axially movable back and
forth in their respective pump bodies P10 and P20 against a return
spring, not represented. The actuating rods P11 and P21, which
project upwards out of the bodies P10 and P20, are movable over
heights of different travel paths, i.e. a long travel path for the
actuating rod P11 and a short travel path for the actuating rod
P21. The pumps P1 and P2 each define a pump chamber of identical or
different volumes.
[0038] Moreover, it can be advantageous for the actuating rods P11
and P21 to have substantially or perfectly identical resistance to
insertion. Otherwise, it may require specific means to compensate
for any difference in resistance to insertion of the two actuating
rods. Each pump P1, P2 also comprises a retaining ring P12, P22 to
mount the pump securely and sealably on the neck of a respective
receptacle (not shown). The type of attachment is not critical and
may vary.
[0039] The dual dispenser disclosed herein also comprises an
opening 3 defining two housings 3P1 and 3P2, respectively for the
pumps P1 and P2. As can be seen in FIG. 2, the retaining rings P12
and P22 fit tightly inside the two housings 3P1 and 3P2, in order
to lock the rings onto the necks of the receptacles. This is a
completely standard configuration in the domain of cosmetics. The
opening 3 can cooperate with a shell (not shown) in which the two
receptacles (not shown) are received.
[0040] The dual dispenser disclosed herein also comprises two caps
C1 and C2 which respectively cover the free ends of the actuating
rods P11 and P21, as can be seen in FIG. 2. The caps C1 and C2 can
be identical, or slightly different, for example to be adapted to
actuating rods of different diameters. Each cap C1, C2 comprises a
support plate C11, C21 as well as a lateral connector fitting C12,
C22. Said connector fitting communicates directly with the
actuating rods P11, P21, in such a way that the fluid products
forced through the actuating rods reach their two connector
fittings C12, C22. The support plates C11, C21 extend substantially
perpendicular to the axis of movement of the actuating rods P11,
P21. Advantageously, each support plate is partially surrounded by
an notched crown C13, C23.
[0041] The dual dispenser disclosed herein also comprises a
pivoting member 1, which can advantageously be formed in one piece.
Said pivoting member 1 comprises an output channel 10, which here
has a rectilinear configuration. The output channel 10 is blocked
at one of end, and at the other end thereof defines an opening 12
in which a spray nozzle 13 is inserted which defines a dispensing
orifice 14. Thus, the fluid product that arrives in the output
channel 10 exits therefrom through the dispensing orifice 14 of the
spray nozzle 13 that blocks the opening 12. It will also be noted
that the two ends of the channel 10 are reinforced so as to define
two thrust transmission zones 11, as will be explained hereinafter.
The output channel 10 comprises two connection fittings 16, 17,
each of which receives a flexible conduit 18, 19 respectively
connected to the connector fittings C12, C22 of the two caps C1 and
C2. The flexible conduits 18 and 19 can be inserted into the
fittings 16, 17, C12 and C22, or as a variant, can be produced from
a single piece together with the pivoting member 1, or with the
caps C1 and C2. It can be seen more clearly in FIG. 3 how the
flexible conduits 18 and 19 connect to the fittings 16, 17, C12 and
C22, while having an angled configuration. It can be noted in FIGS.
1 and 3 that the fitting 16 is disposed near the spray nozzle 13,
and therefore near to the dispensing orifice 14, while the
connection fitting 17 is situated near the end opposite to the
spray nozzle 13. Consequently, the fluid product coming out of the
pump P1 and travelling through the cap C1 and the flexible conduit
18 is injected into the output channel 10 in the immediate vicinity
of the dispensing orifice 14. On the contrary, the fluid product
coming out of the pump P2 must travel through the full length of
the conduit of the output channel 10.
[0042] The pivoting member 1 also forms two support elements 1C1
and 1C2 that extend perpendicular, symmetrically and opposite to
the output channel 10. It could be said that the output channel 10
and the two support elements 1C1 and 1C2 have a configuration that
is generally cross shaped. As a result of this, the two support
elements 1C1 and 1C2 are joined together by means of the output
channel 10. Each support element has the shape of an elongated tab
which defines at its free end a support head 15 which is oriented
downwards, and which comes into contact with the support plate C11,
C21 of the caps C1, C2, as shown in FIG. 2. The support elements
1C1 and 1C2 extend through the notches of the notched crowns C13
and C23 to allow their respective support heads 15 to come into
contact with the support plates C11, C21. Advantageously, support
heads 15 extend in line with the actuating rods P11, P21. It will
also be noted that the support elements 1C1 and 1C2 are connected
to the output channel 10 substantially midway between the two
thrust transmission zones 11 situated at the two opposite ends of
the channel 10.
[0043] The dual dispenser disclosed herein also comprises a cover
2, oval shaped in this instance, which defines an upper support
surface 21 as well as a peripheral skirt 22 through which a hole 23
is made that will face the spray nozzle 13. The cover 2 also
comprises a retaining bushing 24 in which the cap C1 is secured.
Moreover, the cover 2 also comprises a guide bushing 25 that
encloses the cap C2, while allowing it to slide inside. As can be
seen in FIG. 2, the skirt 22 of the cover 2 extends around the
opening 3 so as to completely conceal the caps C1, C2 as well as
the dispensing and support member 1.
[0044] The two caps C1 and C2, the pivoting member 1 and the cover
2 together form the fluid products dispensing head, which is common
to both pumps P1 and P2.
[0045] In FIG. 2, the dispenser is in its rest configuration, with
both actuating rods P11 and P21 in their maximum extended position
outside their respective pump bodies P10, P20. The two support
plates C11 and C21 are situated substantially or perfectly at the
same height. This is obviously also true for the two support heads
15 of the two support elements 1C1 and 1C2. The lower face of the
support surface 21 of the cover 2 is in contact with the output
channel 10 at the two thrust transmission zones 11. Starting from
this rest position, the user presses with one or more fingers on
the support surface 21 of the cover 2 with sufficient thrust force
to move the cover 2 towards the opening 3. The thrust thus exerted
on the cover 2 is transmitted to the output channel 10 at these two
thrust transmission zones 11. The thrust force is then transmitted
through the thrust elements 1C1 and 1C2 to the support heads 15
which are in contact supported on the support plates C11 and C21.
The thrust is then transmitted to the actuating rods P11 and P21,
which are thus forced to be inserted inside their respective pump
bodies P10 and P20. Due to the fact that the actuating rods P11 and
P21 have an identical or nearly identical resistance to insertion,
and to the fact that the support elements 1C1 and 1C2 are
symmetrically identical, the two actuating rods P11 and P21 are
inserted simultaneously until the actuating rod P21, which has the
shortest travel path, is completely inserted. This intermediate and
instantaneous position is represented in FIG. 4. Both actuating
rods P11 and P21 have then traveled the same distance, i.e. the
short distance which is the maximum travel path of the actuating
rod P21. The different fluid products coming out of both pumps P1
and P2 have then been conveyed simultaneously in parallel through
their respective actuating rods P11, 21, their respective caps C1,
C2, their respective flexible conduits 18, 19 to arrive in the
output channel 10 where the two fluid products are mixed before
being dispensed through the single common dispensing orifice 14.
The simultaneous dispensing of the two fluid products has occurred
from the resting configuration of FIG. 2 until the intermediate
configuration of FIG. 4.
[0046] If the user continues exerting pressure on the support
surface 21, the cover 2 will continue moving downwards,
transmitting the thrust to the pivoting member 1 at the two thrust
transmission zones 11 of the output channel 10. Because the head 15
of the support element 1C2 is blocked in position due to the
actuating rod P21 being completely inserted, the thrust transmitted
at the output channel 10 causes an additional downward movement of
the support head 15 of the support element 1C1. This results in the
actuating rod P11 being completely inserted so that it has
completed its long travel path. Over the course of this additional
travel path, the fluid product coming out of the pump P1 has been
injected first into the output channel 10, then through the
dispensing orifice 14. It should be noted that only the fluid
product coming out of the pump P1 passes through the dispensing
orifice 14 at the end of the dispensing phase, the dispensing of
the other fluid product coming out of the pump P2 having been
completed when the actuating rod P21 has completed its short travel
path.
[0047] By comparing FIGS. 4 and 5, it can be seen that the
orientation of the two support elements 1C1 and 1C2 has been
modified. Indeed, in FIG. 4 the two support elements 1C1 and 1C2
are extended in a substantially horizontal plane, while in FIG. 5
the same support elements extend in a plane that is slightly
inclined towards the right. Consequently, with reference to the
cover 2, the support elements 1C1 and 1C2 have made a slight
pivoting or rotational movement around the point of contact of the
support head 15 against the support plate C21. This is also the
case for the output channel 10 which has made a corresponding
slight pivoting. In contrast, with reference to the output channel
10, it can be said that the output channel (10) has made a slight
rotation around its own axis, and the support elements (1C1, 1C2)
have made a pivoting movement around the output channel (10) to
finish the long travel path.
[0048] The fact that the pump P1 is the only to dispense the fluid
product at the end of the dispensing phase makes it possible to
eliminate the fluid product coming out of the pump P2 when the
dispenser is in the resting position. Thus, the fluid product
coming out of the pump P2 is only present in the dispensing orifice
14 during the dispensing phase, and then not in its entirety, since
at the end of the dispensing phase only the product coming out of
the pump P1 is passing through the dispensing orifice 14. It will
then be recalled that the fluid product coming out of the pump P1
is injected into the output channel 10 near the spray nozzle 13, at
the connection fitting 16, as can be seen in FIG. 3. This means
that a very small quantity of fluid product coming out of the pump
P1 is sufficient to eliminate the fluid product coming out of the
pump P2 at the dispensing orifice 14, at the end of the dispensing
phase. In the resting position as represented in FIG. 4, the fluid
product coming out of the pump P2 fills nearly all of the output
channel 10, except for its end near the spray nozzle 13.
[0049] The dual dispenser disclosed herein is particularly
advantageous for dispensing two fluid products of different natures
and/or properties. For example, the fluid product dispensed by the
pump P2 can be a sensitive or easily degradable fluid product,
while the fluid product dispensed by the pump P1 can be another
fluid product that is more stable, more resistant or that has
bactericidal or disinfectant properties. For example, it can be
provided that the pump P1 distributes an alcoholic solution. Thus,
at the end of each dispensing phase, the dispensing orifice 14 is
cleaned by the passage of a small dosage of alcoholic solution that
ensures a perfect cleaning of the spray nozzle 13.
[0050] In this regard, the dual dispenser disclosed herein may be
used in order to prevent the buildup of residual damaged
microcapsules within a dispenser. These residual microcapsules may
in some cases promote clogging. The residual microcapsules may also
leave an unsightly residue at or near the exit orifice that may be
undesirable for a fine fragrance product. Without being limited by
theory, it is believed that the concentration and type of
microcapsule used may in some cases lead to a clogging of the
dispenser. In some examples, pump P1 pumps a first composition
containing a volatile solvent (e.g. ethanol) and pump P2 pumps a
second composition containing microcapsules.
[0051] As shown in FIG. 6, the dual dispenser may also contain a
first receptable R1 for storing a first composition 61 and a second
receptacle R2 for storing a second composition 51, the second
composition containing microcapsules 55. The receptacles R1, R2 may
be of any shape or design. In some examples, a shell may not be
necessary to house the receptacles; a non-limiting example of which
is when the receptacles R1, R2 are made of glass. When the
receptacles are made of glass, the two receptacles may be blown
from the same piece of molten glass, appearing as a single bottle
with two receptacles. Alternatively, when the receptacles are made
of glass, the two receptacles may be blown from separate pieces of
molten glass, appearing as two bottles, each with a single
receptacle, and joined together via a connector. One of ordinary
skill in the art will appreciate that many possible designs of the
receptacles are possible without deviating from the teachings
herein; a non-limiting example of which is a receptacle within a
receptacle.
Compositions
Volatile Solvents
[0052] The compositions described herein may include a volatile
solvent or a mixture of volatile solvents. The volatile solvents
may comprise greater than 10%, greater than 30%, greater than 40%,
greater than 50%, greater than 60%, greater than 70%, or greater
than 90%, by weight of the composition. The volatile solvents
useful herein may be relatively odorless and safe for use on human
skin. Suitable volatile solvents may include C.sub.1-C.sub.4
alcohols and mixtures thereof. Some non-limiting examples of
volatile solvents include ethanol, methanol, propanol, isopropanol,
butanol, and mixtures thereof. In some examples, the composition
may comprise from 0.01% to 98%, by weight of the composition, of
ethanol.
Nonvolatile Solvents
[0053] The composition may comprise a nonvolatile solvent or a
mixture of nonvolatile solvents. Non-limiting examples of
nonvolatile solvents include benzyl benzoate, diethyl phthalate,
isopropyl myristate, propylene glycol, dipropylene glycol, triethyl
citrate, and mixtures thereof.
Fragrances
[0054] The composition may comprise a fragrance. As used herein,
"fragrance" is used to indicate any odoriferous material or a
combination of ingredients including at least one odoriferous
material. Any fragrance that is cosmetically acceptable may be used
in the composition. For example, the fragrance may be one that is a
liquid or solid at room temperature. Generally, the
non-encapsulated fragrance(s) may be present at a level from about
0.001% to about 40%, from about 0.1% to about 25%, from about 0.25%
to about 20%, or from about 0.5% to about 15%, by weight of the
composition. Some fragrances can be considered to be volatiles and
other fragrances can be considered to be or non-volatiles, as
described and defined herein.
[0055] A wide variety of chemicals are known as fragrances,
non-limiting examples of which include alcohols, aldehydes,
ketones, ethers, Schiff bases, nitriles, and esters. More commonly,
naturally occurring plant and animal oils and exudates comprising
complex mixtures of various chemical components are known for use
as fragrances. Non-limiting examples of the fragrances useful
herein include pro-fragrances such as acetal pro-fragrances, ketal
pro-fragrances, ester pro-fragrances, hydrolyzable
inorganic-organic pro-fragrances, and mixtures thereof. The
fragrances may be released from the pro-fragrances in a number of
ways. For example, the fragrance may be released as a result of
simple hydrolysis, or by a shift in an equilibrium reaction, or by
a pH-change, or by enzymatic release. The fragrances herein may be
relatively simple in their chemical make-up, comprising a single
chemical, or may comprise highly sophisticated complex mixtures of
natural and synthetic chemical components, all chosen to provide
any desired odor.
[0056] The fragrances may have a boiling point (BP) of about
500.degree. C. or lower, about 400.degree. C. or lower, or about
350.degree. C. or lower. The BP of many fragrances are disclosed in
Perfume and Flavor Chemicals (Aroma Chemicals), Steffen Arctander
(1969). The ClogP value of the individual fragrance materials may
be about -0.5 or greater. As used herein, "ClogP" means the
logarithm to the base 10 of the octanol/water partition
coefficient. The ClogP can be readily calculated from a program
called "CLOGP" which is available from Daylight Chemical
Information Systems Inc., Irvine Calif., USA or calculated using
Advanced Chemistry Development (ACD/Labs) Software V11.02
(.COPYRGT. 1994-2014 ACD/Labs). Octanol/water partition
coefficients are described in more detail in U.S. Pat. No.
5,578,563.
[0057] Examples of suitable aldehyde include but are not limited
to: alpha-Amylcinnamaldehyde, Anisic Aldehyde, Decyl Aldehyde,
Lauric aldehyde, Methyl n-Nonyl acetaldehyde, Methyl octyl
acetaldehyde, Nonylaldehyde, Benzenecarboxaldehyde, Neral,
Geranial, 2,6 octadiene, 1,1 diethoxy-3,7dimethyl-,
4-Isopropylbenzaldehyde,
2,4-Dimethyl-3-cyclohexene-1-carboxaldehyde,
alpha-Methyl-p-isopropyldihydrocinnamaldehyde,
3-(3-isopropylphenyl) butanal, alpha-Hexylcinnamaldehyde,
7-Hydroxy-3,7-dimethyloctan-1-al,
2,4-Dimethyl-3-Cyclohexene-1-carboxaldehyde, Octyl Aldehyde,
Phenylacetaldehyde, 2,4-Dimethyl-3-Cyclohexene-1-carboxaldehyde,
Hexanal, 3,7-Dimethyloctanal,
6,6-Dimethylbicyclo[3.1.1]hept-2-ene-2-butanal, Nonanal, Octanal,
2-Nonenal Undecenal,
2-Methyl-4-(2,6,6-trimethyl-1-cyclohexenyl-1)-2-butenal,
2,6-Dimethyloctanal3-(p-Isopropylphenyl)propionaldehyde,
3-Phenyl-4-pentenal Citronellal, o/p-Ethyl-alpha,alpha-, 9-Decenal,
dimethyldihydrocinnamaldehyde,
p-Isobutyl-alpha-methylydrocinnamaldehyde, cis-4-Decen-1-al,
2,5-Dimethyl-2-ethenyl-4-hexenal, trans-2-Methyl-2-butenal,
3-Methylnonanal, alpha-Sinensal, 3-Phenylbutanal,
2,2-Dimethyl-3-phenylpropionaldehyde,
m-tert.Butyl-alpha-methyldihydrocinnamic aldehyde, Geranyl
oxyacetaldehyde, trans-4-Decen-1-al, Methoxycitronellal, and
mixtures thereof.
[0058] Examples of suitable esters include but are not limited to:
Allyl cyclohexanepropionate, Allyl heptanoate, Allyl Amyl
Glycolate, Allyl caproate, Amyl acetate (n-Pentyl acetate), Amyl
Propionate, Benzyl acetate, Benzyl propionate, Benzyl salicylate,
cis-3-Hexenylacetate, Citronellyl acetate, Citronellyl propionate,
Cyclohexyl salicylate, Dihydro Isojasmonate Dimethyl benzyl
carbinyl acetate, Ethyl acetate, Ethyl acetoacetate, Ethyl
Butyrate, Ethyl-2-methyl butryrate, Ethyl-2-methyl pentanoate
Fenchyl acetate (1,3,3-Trimethyl-2-norbornanyl acetate),
Tricyclodecenyl acetate, Tricyclodecenyl propionate, Geranyl
acetate, cis-3-Hexenyl isobutyrate, Hexyl acetate, cis-3-Hexenyl
salicylate, n-Hexyl salicylate, Isobornyl acetate, Linalyl acetate,
p-t-Butyl Cyclohexyl acetate, (-)-L-Menthyl acetate,
o-t-Butylcyclohexyl acetate), Methyl benzoate, Methyl dihydro iso
jasmonate, alpha-Methylbenzyl acetate, Methyl salicylate,
2-Phenylethyl acetate, Prenyl acetate, Cedryl acetate, Cyclabute,
Phenethyl phenylacetate, Terpinyl formate, Citronellyl
anthranilate, Ethyl tricyclo[5.2.1.0-2,6]decane-2-carboxylate,
n-Hexyl ethyl acetoacetate, 2-tert.-Butyl-4-methyl-cyclohexyl
acetate, Formic acid, 3,5,5-trimethylhexyl ester, Phenethyl
crotonate, Cyclogeranyl acetate, Geranyl crotonate, Ethyl geranate,
Geranyl isobutyrate, Ethyl 2-nonynoate2,6-Octadienoic acid,
3,7-dimethyl-, methyl ester, Citronellyl valerate,
2-Hexenylcyclopentanone, Cyclohexyl anthranilate, L-Citronellyl
tiglate, Butyl tiglate, Pentyl tiglate, Geranyl caprylate,
9-Decenyl acetate, 2-Isopropyl-5-methylhexyl-1 butyrate, n-Pentyl
benzoate, 2-Methylbutyl benzoate (mixture with pentyl benzoate),
Dimethyl benzyl carbinyl propionate, Dimethyl benzyl carbinyl
acetate, trans-2-Hexenyl salicylate, Dimethyl benzyl carbinyl
isobutyrate, 3,7-Dimethyloctyl formate, Rhodinyl formate, Rhodinyl
isovalerate, Rhodinyl acetate, Rhodinyl butyrate, Rhodinyl
propionate, Cyclohexylethyl acetate, Neryl butyrate,
Tetrahydrogeranyl butyrate, Myrcenyl acetate,
2,5-Dimethyl-2-ethenylhex-4-enoic acid, methyl ester,
2,4-Dimethylcyclohexane-1-methyl acetate, Ocimenyl acetate, Linalyl
isobutyrate, 6-Methyl-5-heptenyl-1 acetate, 4-Methyl-2-pentyl
acetate, n-Pentyl 2-methylbutyrate, Propyl acetate, Isopropenyl
acetate, Isopropyl acetate, 1-Methylcyclohex-3-enecarboxylic acid,
methyl ester, Propyl tiglate, Propyl/isobutyl
cyclopent-3-enyl-1-acetate (alpha-vinyl), Butyl 2-furoate, Ethyl
2-pentenoate, (E)-Methyl 3-pentenoate, 3-Methoxy-3-methylbutyl
acetate, n-Pentyl crotonate, n-Pentyl isobutyrate, Propyl formate,
Furfuryl butyrate, Methyl angelate, Methyl pivalate, Prenyl
caproate, Furfuryl propionate, Diethyl malate, Isopropyl
2-methylbutyrate, Dimethyl malonate, Bornyl formate, Styralyl
acetate, 1-(2-Furyl)-1-propanone, 1-Citronellyl acetate,
3,7-Dimethyl-1,6-nonadien-3-yl acetate, Neryl crotonate,
Dihydromyrcenyl acetate, Tetrahydromyrcenyl acetate, Lavandulyl
acetate, 4-Cyclooctenyl isobutyrate, Cyclopentyl isobutyrate,
3-Methyl-3-butenyl acetate, Allyl acetate, Geranyl formate,
cis-3-Hexenyl caproate, and mixtures thereof.
[0059] Examples of suitable Alcohols include but are not limited
to: Benzyl alcohol, beta-gamma-Hexenol (2-Hexen-1-ol), Cedrol,
Citronellol, Cinnamic alcohol, p-Cresol, Cumic alcohol,
Dihydromyrcenol, 3,7-Dimethyl-1-octanol, Dimethyl benzyl carbinol,
Eucalyptol, Eugenol, Fenchyl alcohol, Geraniol, Hydratopic alcohol,
Isononyl alcohol (3,5,5-Trimethyl-1-hexanol), Linalool, Methyl
Chavicol (Estragole), Methyl Eugenol (Eugenyl methyl ether), Nerol,
2-Octanol, Patchouli alcohol, Phenyl Hexanol
(3-Methyl-5-phenyl-1-pentanol), Phenethyl alcohol, alpha-Terpineol,
Tetrahydrolinalool, Tetrahydromyrcenol, 4-methyl-3decen-5-ol,
1-3,7-Dimethyloctane-1-ol, 2-(Furfuryl-2)-heptanol,
6,8-Dimethyl-2-nonanol, Ethyl norbornyl cyclohexanol, beta-Methyl
cyclohexane ethanol, 3,7-Dimethyl-(2),6-octen(adien)-1-ol,
trans-2-Undecen-1-ol 2-Ethyl-2-prenyl-3-hexenol, Isobutyl benzyl
carbinol, Dimethyl benzyl carbinol, Ocimenol,
3,7-Dimethyl-1,6-nonadien-3-ol (cis & trans),
Tetrahydromyrcenol, alpha-Terpineol, 9-Decenol-1, 2
(Hexenyl)cyclopentanol, 2,6-Dimethyl-2-heptanol,
3-Methyl-1-octen-3-ol, 2,6-Dimethyl-5-hepten-2-ol,
3,7,9-Trimethyl-1,6-decadien-3-ol, 3,7-Dimethyl-6-nonen-1-ol,
3,7-Dimethyl-1-octyn-3-ol, 2,6-Dimethyl-1,5,7-octatrienol-3,
Dihydromyrcenol, 2,6,10-Trimethyl-5,9-undecadienol,
2,5-Dimethyl-2-propylhex-4-enol-1,(Z),3-Hexenol,
o,m,p-Methyl-phenylethanol, 2-Methyl-5-phenyl-1-pentanol,
3-Methylphenethyl alcohol, para-Methyl dimethyl benzyl carbinol,
Methyl benzyl carbinol, p-Methylphenylethanol,
3,7-Dimethyl-2-octen-1-ol, 2-Methyl-6-methylene-7-octen-4-ol, and
mixtures thereof.
[0060] Examples of ketones include but are not limited to:
Oxacycloheptadec-10-en-2-one, Benzylacetone, Benzophenone,
L-Carvone, cis-Jasmone,
4-(2,6,6-Trimethyl-3-cyclohexen-1-yl)-but-3-en-4-one, Ethyl amyl
ketone, alpha-Ionone, Ionone Beta, Ethanone,
Octahydro-2,3,8,8-tetramethyl-2-acetonaphthalene, alpha-Irone,
1-(5,5-Dimethyl-1-cyclohexen-1-yl)-4-penten-1-one, 3-Nonanone,
Ethyl hexyl ketone, Menthone, 4-Methylacetophenone, gamma-Methyl
Ionone Methyl pentyl ketone, Methyl Heptenone
(6-Methyl-5-hepten-2-one), Methyl Heptyl ketone, Methyl Hexyl
ketone, delta Muscenone, 2-Octanone,
2-Pentyl-3-methyl-2-cyclopenten-1-one, 2-Heptylcyclopentanone,
alpha-Methylionone, 3-Methyl-2-(trans-2-pentenyl)-cyclopentenone,
Octenyl cyclopentanone, n-Amylcyclopentenone,
6-Hydroxy-3,7-dimethyloctanoic acid lactone,
2-Hydroxy-2-cyclohexen-1-one, 3-Methyl-4-phenyl-3-buten-2-one,
2-Pentyl-2,5,5-trimethylcyclopentanone,
2-Cyclopentylcyclopentanol-1, 5-Methylhexan-2-one,
gamma-Dodecalactone, delta-Dodecalactone delta-Dodecalactone,
gamma-Nonalactone, delta-Nonalactone, gamma-Octalactone,
delta-Undecalactone, gamma-Undecalactone, and mixtures thereof.
[0061] Examples of ethers include but are not limited to: p-Cresyl
methyl ether,
4,6,6,7,8,8-Hexamethyl-1,3,4,6,7,8-hexahydro-cyclopenta(G)-2-benzo-
pyran, beta-Naphthyl methyl ether, Methyl Iso Butenyl Tetrahydro
Pyran, (Phantolide) 5-Acetyl-1,1,2,3,3,6 hexamethylindan,
(Tonalid)7-Acetyl-1,1,3,4,4,6-hexamethyltetralin, 2-Phenylethyl
3-methylbut-2-enyl ether, Ethyl geranyl ether, Phenylethyl
isopropyl ether, and mixtures thereof.
[0062] Examples of alkenes include but are not limited to:
Allo-Ocimene, Camphene, beta-Caryophyllene, Cadinene,
Diphenylmethane, d-Limonene, Lymolene, beta-Myrcene, Para-Cymene,
alpha-Pinene, beta-Pinene, alpha-Terpinene, gamma-Terpinene,
Terpineolene, 7-Methyl-3-methylene-1,6-octadiene, and mixtures
thereof.
[0063] Examples of nitriles include but are not limited to:
3,7-Dimethyl-6-octenenitrile, 3,7-Dimethyl-2(3),
6-nonadienenitrile, (2E, 6Z) 2,6-nonadienenitrile, n-dodecane
nitrile, and mixtures thereof.
[0064] Examples of Schiffs Bases include but are not limited to:
Citronellyl nitrile, Nonanal/methyl anthranilate, Anthranilic acid,
N-octylidene-, methyl ester(L)-, Hydroxycitronellal/methyl
anthranilate, 2-Methyl-3-(4-Cyclamen aldehyde/methyl anthranilate,
methoxyphenyl propanal/Methyl anthranilate, Ethyl
p-aminobenzoate/hydroxycitronellal, Citral/methyl anthranilate,
2,4-Dimethylcyclohex-3-enecarbaldehyde methyl anthranilate,
Hydroxycitronellal-indole, and mixtures thereof.
[0065] Non-limiting examples of fragrances include fragrances such
as musk oil, civet, castoreum, ambergris, plant fragrances such as
nutmeg extract, cardomon extract, ginger extract, cinnamon extract,
patchouli oil, geranium oil, orange oil, mandarin oil, orange
flower extract, cedarwood, vetyver, lavandin, ylang extract,
tuberose extract, sandalwood oil, bergamot oil, rosemary oil,
spearmint oil, peppermint oil, lemon oil, lavender oil, citronella
oil, chamomille oil, clove oil, sage oil, neroli oil, labdanum oil,
eucalyptus oil, verbena oil, mimosa extract, narcissus extract,
carrot seed extract, jasmine extract, olibanum extract, rose
extract, and mixtures thereof.
Carriers and Water
[0066] When the composition contains microcapsules, the composition
may include a carrier for the microcapsules. Non-limiting examples
of carriers include water, silicone oils like silicone D5, and
other oils like mineral oil, isopropyl myristate, and fragrance
oils. The carrier should be one that does not significantly affect
the performance of the microcapsules. Non-limiting examples of
non-suitable carriers for the microcapsules include volatile
solvents like 95% ethanol.
[0067] The compositions containing microcapsules may include about
0.1% to about 95%, from about 5% to about 95%, or from 5% to 75%,
by weight of the composition, of the carrier. When the composition
contains a volatile solvent, the composition may include from about
0.01% to about 40%, from about 0.1% to about 30%, or from about
0.1% to about 20%, by weight of the composition, of water.
[0068] In some examples, when a first composition containing a
volatile solvent and a second composition containing microcapsules
are sprayed, the dose containing the mixture of the first and
second compositions may contain about 0.01% to about 75%, from
about 1% to about 60%, from about 0.01% to about 60%, or from about
5% to about 50%, by weight of the composition, of water.
Encapsulates
[0069] The microcapsules may be any kind of microcapsule disclosed
herein or known in the art. The microcapsules may be included from
about 0.01% to about 45%, by weight, of the composition. The
microcapsules may have a shell and a core material encapsulated by
the shell. The core material of the microcapsules may include one
or more perfume oils. The shells of the microcapsules may be made
from synthetic polymeric materials or naturally-occurring polymers.
Synthetic polymers may be derived from petroleum oil, for example.
Non-limiting examples of synthetic polymers include nylon,
polyethylenes, polyamides, polystyrenes, polyisoprenes,
polycarbonates, polyesters, polyureas, polyurethanes, polyolefins,
polysaccharides, epoxy resins, vinyl polymers, polyacrylates, and
mixtures thereof. Natural polymers occur in nature and may often be
extracted from natural materials. Non-limiting examples of
naturally occurring polymers are silk, wool, gelatin, cellulose,
proteins, and combinations thereof.
[0070] The microcapsules may be friable microcapsules. A friable
microcapsule is configured to release its core material when its
shell is ruptured. The rupture may be caused by forces applied to
the shell during mechanical interactions. The microcapsules may
have a shell with a volume weighted fracture strength of from about
0.1 mega Pascals to about 15.0 mega Pascals, when measured
according to the Fracture Strength Test Method described herein, or
any incremental value expressed in 0.1 mega Pascals in this range,
or any range formed by any of these values for fracture strength.
As an example, a microcapsule may have a shell with a volume
weighted fracture strength of 0.8-15.0 mega Pascals (MPa),
alternatively from 5.0-12.0 mega Pascals (MPa), or alternatively
from 6.0-10.0 mega Pascals (MPa).
[0071] The microcapsules may have a median volume-weighted particle
size of from 2 microns to 80 microns, from 10 microns to 30
microns, or from 10 microns to 20 microns, as determined by the
Test Method for Determining Median Volume-Weighted Particle Size of
Microcapsules described herein.
[0072] The microcapsules may have various core material to shell
weight ratios. The microcapsules may have a core material to shell
ratio that is greater than or equal to: 70% to 30%, 75% to 25%, 80%
to 20%, 85% to 15%, 90% to 10%, and 95% to 5%.
[0073] The microcapsules may have shells made from any material in
any size, shape, and configuration known in the art. Some or all of
the shells may include a polyacrylate material, such as a
polyacrylate random copolymer. For example, the polyacrylate random
copolymer may have a total polyacrylate mass, which includes
ingredients selected from the group including: amine content of
0.2-2.0% of total polyacrylate mass; carboxylic acid of 0.6-6.0% of
total polyacrylate mass; and a combination of amine content of
0.1-1.0% and carboxylic acid of 0.3-3.0% of total polyacrylate
mass.
[0074] When a microcapsule's shell includes a polyacrylate
material, and the shell has an overall mass, the polyacrylate
material may form 5-100% of the overall mass, or any integer value
for percentage in this range, or any range formed by any of these
values for percentage. As examples, the polyacrylate material may
form at least 5%, at least 10%, at least 25%, at least 33%, at
least 50%, at least 70%, or at least 90% of the overall mass.
[0075] Some or all of the microcapsules may have various shell
thicknesses. For at least a first group of the provided
microcapsules, each microcapsule may have a shell with an overall
thickness of 1-300 nanometers, or any integer value for nanometers
in this range, or any range formed by any of these values for
thickness. As an example, microcapsules may have a shell with an
overall thickness of 2-200 nanometers.
[0076] The microcapsules may also encapsulate one or more benefit
agents. The benefit agent(s) include, but are not limited to,
cooling sensates, warming sensates, perfume oils, oils, pigments,
dyes, chromogens, phase change materials, and other kinds of
benefit agent known in the art, in any combination. In some
examples, the perfume oil encapsulated may have a ClogP of less
than 4.5 or a ClogP of less than 4. Alternatively the perfume oil
encapsulated may have a ClogP of less than 3. In some examples, the
microcapsule may be anionic, cationic, zwitterionic, or have a
neutral charge. The benefit agents(s) may be in the form of solids
and/or liquids. The benefit agent(s) may be any kind of perfume
oil(s) known in the art, in any combination.
[0077] The microcapsules may encapsulate a partitioning modifier in
addition to the benefit agent. Non-limiting examples of
partitioning modifiers include isopropyl myristate, mono-, di-, and
tri-esters of C.sub.4-C.sub.24 fatty acids, castor oil, mineral
oil, soybean oil, hexadecanoic acid, methyl ester isododecane,
isoparaffin oil, polydimethylsiloxane, brominated vegetable oil,
and combinations thereof. Microcapsules may also have varying
ratios of the partitioning modifier to the benefit agent so as to
make different populations of microcapsules that may have different
bloom patterns. Such populations may also incorporate different
perfume oils so as to make populations of microcapsules that
display different bloom patterns and different scent experiences.
U.S. 2011-0268802 discloses other non-limiting examples of
microcapsules and partitioning modifiers and is hereby incorporated
by reference.
[0078] The microcapsule's shell may comprise a reaction product of
a first mixture in the presence of a second mixture comprising an
emulsifier, the first mixture comprising a reaction product of i)
an oil soluble or dispersible amine with ii) a multifunctional
acrylate or methacrylate monomer or oligomer, an oil soluble acid
and an initiator, the emulsifier comprising a water soluble or
water dispersible acrylic acid alkyl acid copolymer, an alkali or
alkali salt, and optionally a water phase initiator. In some
examples, said amine is an aminoalkyl acrylate or aminoalkyl
methacrylate.
[0079] The microcapsules may include a core material and a shell
surrounding the core material, wherein the shell comprises: a
plurality of amine monomers selected from the group consisting of
aminoalkyl acrylates, alkyl aminoalkyl acrylates, dialkyl
aminoalykl acrylates, aminoalkyl methacrylates, alkylamino
aminoalkyl methacrylates, dialkyl aminoalykl methacrylates,
tertiarybutyl aminethyl methacrylates, diethylaminoethyl
methacrylates, dimethylaminoethyl methacrylates, dipropylaminoethyl
methacrylates, and mixtures thereof; and a plurality of
multifunctional monomers or multifunctional oligomers. Non-limiting
examples of emulsifiers include water-soluble salts of alkyl
sulfates, alkyl ether sulfates, alkyl isothionates, alkyl
carboxylates, alkyl sulfosuccinates, alkyl succinamates, alkyl
sulfate salts such as sodium dodecyl sulfate, alkyl sarcosinates,
alkyl derivatives of protein hydrolyzates, acyl aspartates, alkyl
or alkyl ether or alkylaryl ether phosphate esters, sodium dodecyl
sulphate, phospholipids or lecithin, or soaps, sodium, potassium or
ammonium stearate, oleate or palmitate, alkylarylsulfonic acid
salts such as sodium dodecylbenzenesulfonate, sodium
dialkylsulfosuccinates, dioctyl sulfosuccinate, sodium
dilaurylsulfosuccinate, poly(styrene sulfonate) sodium salt,
isobutylene-maleic anhydride copolymer, gum arabic, sodium
alginate, carboxymethylcellulose, cellulose sulfate and pectin,
poly(styrene sulfonate), isobutylene-maleic anhydride copolymer,
gum arabic, carrageenan, sodium alginate, pectic acid, tragacanth
gum, almond gum and agar; semi-synthetic polymers such as
carboxymethyl cellulose, sulfated cellulose, sulfated
methylcellulose, carboxymethyl starch, phosphated starch, lignin
sulfonic acid; and synthetic polymers such as maleic anhydride
copolymers (including hydrolyzates thereof), polyacrylic acid,
polymethacrylic acid, acrylic acid butyl acrylate copolymer or
crotonic acid homopolymers and copolymers, vinylbenzenesulfonic
acid or 2-acrylamido-2-methylpropanesulfonic acid homopolymers and
copolymers, and partial amide or partial ester of such polymers and
copolymers, carboxymodified polyvinyl alcohol, sulfonic
acid-modified polyvinyl alcohol and phosphoric acid-modified
polyvinyl alcohol, phosphated or sulfated tristyrylphenol
ethoxylates, palmitamidopropyltrimonium chloride (Varisoft
PATC.TM., available from Degussa Evonik, Essen, Germany), distearyl
dimonium chloride, cetyltrimethylammonium chloride, quaternary
ammonium compounds, fatty amines, aliphatic ammonium halides,
alkyldimethylbenzylammonium halides, alkyldimethylethylammonium
halides, polyethyleneimine, poly(2-dimethylamino)ethyl
methacrylate) methyl chloride quaternary salt,
poly(l-vinylpyrrolidone-co-2-dimethylaminoethyl methacrylate),
poly(acrylamide-co-diallyldimethylammonium chloride),
poly(allylamine), poly[bis (2-chloroethyl) ether-alt-1,3-bis
[3-(dimethylamino)propyl]urea] quaternized, and
poly(dimethylamine-co-epichlorohydrin-co-ethylenediamine),
condensation products of aliphatic amines with alkylene oxide,
quaternary ammonium compounds with a long-chain aliphatic radical,
e.g. distearyldiammonium chloride, and fatty amines,
alkyldimethylbenzylammonium halides, alkyldimethylethylammonium
halides, polyalkylene glycol ether, condensation products of alkyl
phenols, aliphatic alcohols, or fatty acids with alkylene oxide,
ethoxylated alkyl phenols, ethoxylated arylphenols, ethoxylated
polyaryl phenols, carboxylic esters solubilized with a polyol,
polyvinyl alcohol, polyvinyl acetate, or copolymers of polyvinyl
alcohol polyvinyl acetate, polyacrylamide,
poly(N-isopropylacrylamide), poly(2-hydroxypropyl methacrylate),
poly(-ethyl-2-oxazoline), poly(2-isopropenyl-2-oxazoline-co-methyl
methacrylate), poly(methyl vinyl ether), and polyvinyl
alcohol-co-ethylene), and cocoamidopropyl betaine.
[0080] Processes for making microcapsules are well known. Various
processes for microencapsulation, and exemplary methods and
materials, are set forth in U.S. Pat. No. 6,592,990; U.S. Pat. No.
2,730,456; U.S. Pat. No. 2,800,457; U.S. Pat. No. 2,800,458; U.S.
Pat. No. 4,552,811; and U.S. 2006/0263518 A1.
[0081] The microcapsule may be spray-dried to form spray-dried
microcapsules. The composition may also contain one or more
additional delivery systems for providing one or more benefit
agents, in addition to the microcapsules. The additional delivery
system(s) may differ in kind from the microcapsules. For example,
wherein the microcapsule encapsulates a perfume oil, the additional
delivery system may be an additional fragrance delivery system,
such as a moisture-triggered fragrance delivery system.
Non-limiting examples of moisture-triggered fragrance delivery
systems include cyclic oligosaccaride, starch (or other
polysaccharide material), starch derivatives, and combinations
thereof. Said polysaccharide material may or may not be
modified.
[0082] The plurality of microcapsules may include anionic,
cationic, and non-ionic microcapsules, in any combination, when
included in a composition with a pH range of from 2 to about10,
alternatively from about 3 to about 9, alternatively from about 4
to about 8.
[0083] In some examples, the microcapsules may include a benefit
agent comprising: a.) a perfume composition having a ClogP of less
than 4.5; b.) a perfume composition comprising, based on total
perfume composition weight, 60% perfume materials having a ClogP of
less than 4.0; c.) a perfume composition comprising, based on total
perfume composition weight, 35% perfume materials having a ClogP of
less than 3.5; d.) a perfume composition comprising, based on total
perfume composition weight, 40% perfume materials having a ClogP of
less than 4.0 and at least 1% perfume materials having a ClogP of
less than 2.0; e.) a perfume composition comprising, based on total
perfume composition weight, 40% perfume materials having a ClogP of
less than 4.0 and at least 15% perfume materials having a ClogP of
less than 3.0; f.) a perfume composition comprising, based on total
perfume composition weight, at least 1% butanoate esters and at
least 1% of pentanoate esters; g.) a perfume composition
comprising, based on total perfume composition weight, at least 2%
of an ester comprising an allyl moiety and at least 10% of another
perfume comprising an ester moiety; h.) a perfume composition
comprising, based on total perfume composition weight, at least 1%
of an aldehyde comprising an alkyl chain moiety; i.) a perfume
composition comprising, based on total perfume composition weight,
at least 2% of a butanoate ester; j.) a perfume composition
comprising, based on total perfume composition weight, at least 1%
of a pentanoate ester; k.) a perfume composition comprising, based
on total perfume composition weight, at least 3% of an ester
comprising an allyl moiety and 1% of an aldehyde comprising an
alkyl chain moiety; l.) a perfume composition comprising, based on
total perfume composition weight, at least 25% of a perfume
comprising an ester moiety and 1% of an aldehyde comprising an
alkyl chain moiety; m.) a perfume composition comprising, based on
total perfume composition weight, at least 2% of a material
selected from 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one,
4-(2,6,6-trimethyl-2-cyclohexenyl)-3-buten-2-one and
3-buten-2-one,3-methyl-4-(2,6,6-trimethyl-1-cyclohexen-2-yl)- and
mixtures thereof; n.) a perfume composition comprising, based on
total perfume composition weight, at least 0.1% of
tridec-2-enonitrile, and mandaril, and mixtures thereof; o.) a
perfume composition comprising, based on total perfume composition
weight, at least 2% of a material selected from
3,7-dimethyl-6-octene nitrile,
2-cyclohexylidene-2-phenylacetonitrile and mixtures thereof; p.) a
perfume composition comprising, based on total perfume composition
weight, at least 80% of one or more perfumes comprising a moiety
selected from the group consisting of esters, aldehydes, ionones,
nitriles, ketones and combinations thereof; q.) a perfume
composition comprising, based on total perfume composition weight,
at least 3% of an ester comprising an allyl moiety; a perfume
composition comprising, based on total perfume composition weight,
at least 20% of a material selected from the group consisting of:
1-methylethyl-2-methylbutanoate; ethyl-2-methyl pentanoate;
1,5-dimethyl-1-ethenylhexyl-4-enyl acetate; p-meth-1-en-8-yl
acetate; 4-(2,6,6-trimethyl-2-cyclohexenyl)-3-buten-2-one;
4-acetoxy-3-methoxy-1-propenylbenzene; 2-propenyl
cyclohexanepropionate; bicyclo [2.2.1]hept-5-ene-2-carboxylic
acid,3-(1-methylethyl)-ethyl ester; bycyclo [2.2.1]heptan-2-ol,
1,7,7-trimethyl-, acetate; 1,5-dimethyl-1-ethenylhex-4-enylacetate;
hexyl 2-methyl propanoate; ethyl-2-methylbutanoate; 4-undecanone;
5-heptyldihydro-2(3h)-furanone; 1,6-nonadien-3-ol, 3,7dimethyl-;
3,7-dimethylocta-1,6-dien-3-o;
3-cyclohexene-1-carboxaldehyde,dimethyl-;3,7-dimethyl-6-octene
nitrile; 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one;
tridec-2-enonitrile; patchouli oil; ethyl tricycle
[5.2.1.0]decan-2-carboxylate; 2,2-dimethyl-cyclohexanepropanol;
hexyl ethanoate,
7-acetyl,1,2,3,4,5,6,7,8-octahydro-1,1,6,7-tetramethyl naphtalene;
allyl-cyclohexyloxy acetate; methyl nonyl acetic aldehyde;
1-spiro[4,5]dec-7-en-7-yl-4-pentenen-1-one; 7-octen-2-ol,
2-methyl-6-methylene-, dihydro; cyclohexanol,
2-(1,1-dimethylethyl)-, acetate; hexahydro-4,7-methanoinden-5(6)-yl
propionatehexahydro-4,7-methanoinden-5(6)-yl propionate;
2-methoxynaphtalene;
1-(2,6,6-trimethyl-3-cyclohexenyl)-2-buten-1-one;
1-(2,6,6-trimethyl-2-cyclohexenyl)-2-buten-1-one;
3,7-dimethyloctan-3-ol; 3-buten-2-one,
3-methyl-4-(2,6,6-trimehtyl-1-cyclohexen-2-yl)-; hexanoic acid,
2-propenyl ester; (z)-non-6-en-1-al; 1-decyl aldehyde; 1-octanal;
4-t-butyl-methylhydrocinnamaldehyde; alpha-hexylcinnamaldehyde;
ethyl-2,4-hexadienoate; 2-propenyl 3-cyclohexanepropanoate; and
mixtures thereof; r.) a perfume composition comprising, based on
total perfume composition weight, at least 20% of a material
selected from the group consisting of:
1-methylethyl-2-methylbutanoate; ethyl-2-methyl pentanoate;
1,5-dimethyl-1-ethenylhex-4-enyl acetate; p-menth-1-en-8-yl
acetate; 4-(2,6,6-trimethyl-2-cyclohexenyl)-3-buten-2-one;
4-acetoxy-3-methoxy-1-propenylbenzene; 2-propenyl
cyclohexanepropionate; bicyclo [2.2.1]hept-5-ene-2-carboxylic
acid,3-(1-methylethyl)-ethyl ester; bycyclo [2.2.1]heptan-2-ol,
1,7,7-trimethyl-, acetate; 1,5-dimethyl-1-ethenylhex-4-enyl
acetate; hexyl 2-methyl propanoate; ethyl-2-methylbutanoate,
4-undecanolide; 5-heptyldihydro-2(3h)-furanone; 5-hydroxydodecanoic
acid; decalactones; undecalactones, 1,6-nonadien-3-ol,
3,7dimethyl-; 3,7-dimethylocta-1,6-dien-3-ol;
3-cyclohexene-1-carboxaldehyde,dimethyl-; 3,7-dimethyl-6-octene
nitrile; 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one;
tridec-2-enonitrile; patchouli oil; ethyl tricycle
[5.2.1.0]decan-2-carboxylate; 2,2-dimethyl-cyclohexanepropanol;
allyl-cyclohexyloxy acetate; methyl nonyl acetic aldehyde;
1-spiro[4,5]dec-7-en-7-yl-4-pentenen-1-one; 7-octen-2-ol,
2-methyl-6-methylene-, dihydro, cyclohexanol,
2-(1,1-dimethylethyl)-, acetate; hexahydro-4,7-methanoinden-5(6)-yl
propionatehexahydro-4,7-methanoinden-5(6)-yl propionate;
2-methoxynaphtalene;
1-(2,6,6-trimethyl-3-cyclohexenyl)-2-buten-1-one;1-(2,6,6-trimethyl-2-cyc-
lohexenyl)-2-buten-1-one; 3,7-dimethyloctan-3-ol;
3-buten-2-one,3-methyl-4-(2,6,6-trimehtyl-1-cyclohexen-2-yl)-;
hexanoic acid, 2-propenyl ester; (z)-non-6-en-1-al; 1-decyl
aldehyde; 1-octanal; 4-t-butyl-methylhydrocinnamaldehyde;
ethyl-2,4-hexadienoate; 2-propenyl 3-cyclohexanepropanoate; and
mixtures thereof; s.) a perfume composition comprising, based on
total perfume composition weight, at least 5% of a material
selected from the group consisting of
3-cyclohexene-1-carboxaldehyde,dimethyl-;
3-buten-2-one,3-methyl-4-(2,6,6-trimehtyl-1-cyclohexen-2-yl)-;
patchouli oil; Hexanoic acid, 2-propenyl ester; 1-Octanal; 1-decyl
aldehyde; (z)-non-6-en-1-al; methyl nonyl acetic aldehyde;
ethyl-2-methylbutanoate; 1-methylethyl-2-methylbutanoate;
ethyl-2-methyl pentanoate; 4-hydroxy-3-ethoxybenzaldehyde;
4-hydroxy-3-methoxybenzaldehyde; 3-hydroxy-2-methyl-4-pyrone;
3-hydroxy-2-ethyl-4-pyrone and mixtures thereof; t.) a perfume
composition comprising, based on total perfume composition weight,
less than 10% perfumes having a ClogP greater than 5.0; u.) a
perfume composition comprising geranyl palmitate; or v.) a perfume
composition comprising a first and an optional second material,
said first material having: (i) a ClogP of at least 2; (ii) a
boiling point of less than about 280.degree. C.; and second
optional second material, when present, having (i) a ClogP of less
than 2.5; and (ii) a ODT of less than about 100 ppb.
[0084] In some examples, the microcapsules may include a benefit
agent comprising: one or more materials selected from the group
consisting of (5-methyl-2-propan-2-ylcyclohexyl) acetate;
3,7-dimethyloct-6-en-1-al; 2-(phenoxy)ethyl 2-methylpropanoate;
prop-2-enyl 2-(3-methylbutoxy)acetate; 3-methyl-1-isobutylbutyl
acetate; prop-2-enyl hexanoate; prop-2-enyl 3-cyclohexylpropanoate;
prop-2-enyl heptanoate;
(E)-1-(2,6,6-trimethyl-1-cyclohex-2-enyl)but-2-en-1-one;
(E)-4-(2,6,6-trimethyl-1-cyclohex-2-enyl)but-3-en-2-one;
(E)-3-methyl-4-(2,6,6-trimethyl-1-cyclohex-2-enyl)but-3-en-2-one;
1-(2,6,6-trimethyl-1-cyclohex-2-enyl)pent-1-en-3-one;
6,6,9a-trimethyl-1,2,3a,4,5,5a,7,8,9,9b-decahydronaphtho
[2,1-b]furan; pentyl 2-hydroxybenzoate;
7,7-dimethyl-2-methylidene-norbornane;
(E)-1-(2,6,6-trimethyl-1-cyclohexenyl)but-2-en-1-one;
(E)-4-(2,6,6-trimethyl-1-cyclohexenyl)but-3-en-2-one;
4-ethoxy-4,8,8-trimethyl-9-methylidenebicyclo [3.3.1]nonane;
(1,7,7-trimethyl-6-bicyclo [2.2.1]heptanyl) acetate;
3-(4-tert-butylphenyl)propanal;
1,1,2,3,3-pentamethyl-2,5,6,7-tetrahydroinden-4-one;
2-oxabicyclo2.2.2octane, 1methyl4(2,2,3trimethylcyclopentyl);
[(Z)-hex-3-enyl] acetate; [(Z)-hex-3-enyl] 2-methylbutanoate;
cis-3-hexenyl 2-hydroxybenzoate; 3,7-dimethylocta-2,6-dienal;
3,7-dimethyloct-6-en-1-al; 3,7-dimethyl-6-octen-1-ol;
3,7-dimethyloct-6-enyl acetate; 3,7-dimethyloct-6-enenitrile;
2-(3,7-dimethyloct-6-enoxy)acetaldehyde;
tetrahydro-4-methyl-2-propyl-2h-pyran-4-yl acetate; ethyl
3-phenyloxirane-2-carboxylate; hexahydro-4,7-methano-indenyl
isobutyrate; 2,4-dimethylcyclohex-3-ene-1-carbaldehyde;
hexahydro-4,7-methano-indenyl propionate; 2-cyclohexylethyl
acetate; 2-pentylcyclopentan-1-ol;
(2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-(6-cyclohexylhexoxy)-4,5-dihydroxy-
-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;
(E)-1-(2,6,6-trimethyl-1-cyclohexa-1,3-dienyl)but-2-en-1-one;
1-cyclohexylethyl (E)-but-2-enoate; dodecanal;
(E)-1-(2,6,6-trimethyl-1-cyclohex-3-enyl)but-2-en-1-one;
(5E)-3-methylcyclopentadec-5-en-1-one;
4-(2,6,6-trimethyl-1-cyclohex-2-enyl)butan-2-one;
2-methoxy-4-propylphenol; methyl
2-hexyl-3-oxocyclopentane-1-carboxylate; 2,6-dimethyloct-7-en-2-ol;
4,7-dimethyloct-6-en-3-one;
4-(octahydro-4,7-methano-5H-inden-5-yliden)butanal; acetaldehyde
ethyl linalyl acetal; ethyl 3,7-dimethyl-2,6-octadienoate; ethyl
2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate; 2-ethylhexanoate;
(6E)-3,7-dimethylnona-1,6-dien-3-ol; ethyl 2-methylbutanoate; ethyl
2-methylpentanoate; ethyl tetradecanoate; ethyl nonanoate; ethyl
3-phenyloxirane-2-carboxylate;
1,4-dioxacycloheptadecane-5,17-dione; 1,3,3-trimethyl-2-oxabicyclo
[2,2,2] octane; [essential oil]; oxacyclo-hexadecan-2-one;
3-(4-ethylphenyl)-2,2-dimethylpropanal;
2-butan-2-ylcyclohexan-1-one; 1,4-cyclohexandicarboxylic acid,
diethyl ester;
(3aalpha,4beta,7beta,7aalpha)-octahydro-4,7-methano-3aH-indene-3a--
carboxylic acid ethyl ester; hexahydro-4-7, menthano-1H-inden-6-yl
propionate; 2-butenon-1-one,1-(2,6-dimethyl-6-methylencyclohexyl)-;
(E)-4-(2,2-dimethyl-6-methylidenecyclohexyl)but-3-en-2-one;
1-methyl-4-propan-2-ylcyclohexa-1,4-diene; 5-heptyloxolan-2-one;
3,7-dimethylocta-2,6-dien-1-ol; [(2E)-3,7-dimethylocta-2,6-dienyl]
acetate; [(2E)-3,7-dimethylocta-2,6-dienyl] octanoate; ethyl
2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate;
(4-methyl-1-propan-2-yl-1-cyclohex-2-enyl) acetate;
2-butyl-4,6-dimethyl-5,6-dihydro-2H-pyran; oxacyclohexadecen-2-one;
1-propanol,
2-[1-(3,3-dimethyl-cyclohexyl)ethoxy]-2-methyl-propanoate; 1-heptyl
acetate; 1-hexyl acetate; hexyl 2-methylpropanoate;
(2-(1-ethoxyethoxy)ethyl)benzene; 4,4a,5,9b-tetrahydroindeno
[1,2-d][1,3]dioxine; undec-10-enal;
3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one;
1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-ethan-1--
one; 7-acetyl,1,2,3,4,5,6,7-octahydro-1,1,6,7,-tetra methyl
naphthalene; 3-methylbutyl 2-hydroxybenzoate;
[(1R,4S,6R)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl]
acetate;[(1R,4R,6R)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl]
2-methylpropanoate; (1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)
propanoate; 2-methylpropyl hexanoate;
[2-methoxy-4-[(E)-prop-1-enyl]phenyl] acetate;
2-hexylcyclopent-2-en-1-one;
5-methyl-2-propan-2-ylcyclohexan-1-one; 7-methyloctyl acetate;
propan-2-yl 2-methylbutanoate; 3,4,5,6,6-pentamethylheptenone-2;
hexahydro-3,6-dimethyl-2(3H)-benzofuranone;
2,4,4,7-tetramethyl-6,8-nonadiene-3-one oxime; dodecyl acetate;
[essential oil]; 3,7-dimethylnona-2,6-dienenitrile;
[(Z)-hex-3-enyl] methyl carbonate;
2-methyl-3-(4-tert-butylphenyl)propanal;
3,7-dimethylocta-1,6-dien-3-ol; 3,7-dimethylocta-1,6-dien-3-yl
acetate; 3,7-dimethylocta-1,6-dien-3-yl butanoate;
3,7-dimethylocta-1,6-dien-3-yl formate;
3,7-dimethylocta-1,6-dien-3-yl 2-methylpropanoate;
3,7-dimethylocta-1,6-dien-3-yl propanoate;
3-methyl-7-propan-2-ylbicyclo [2.2.2] oct-2-ene-5-carbaldehyde;
2,2-dimethyl-3-(3-methylphenyl)propan-1-ol;
3-(4-tert-butylphenyl)butanal; 2,6-dimethylhept-5-enal;
5-methyl-2-propan-2-yl-cyclohexan-1-ol;
1-(2,6,6-trimethyl-1-cyclohexenyl)pent-1-en-3-one; methyl
3-oxo-2-pentylcyclopentaneacetate; methyl tetradecanoate;
2-methylundecanal; 2-methyldecanal;
1,1-dimethoxy-2,2,5-trimethyl-4-hexene;
[(1S)-3-(4-methylpent-3-enyl)-1-cyclohex-3-enyl]methyl acetate;
2-(2-(4-methyl-3-cyclohexen-1-yl)propyl)cyclo-pentanone;
4-penten-1-one, 1-(5,5-dimethyl-1-cyclohexen-1-yl;
1H-indene-ar-propanal, 2,3,-dihydro-1,1-dimethyl-(9CI);
2-ethoxynaphthalene; nonanal;
2-(7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)ethyl acetate; octanal;
4-(1-methoxy-1-methylethyl)-1-methylcyclohexene;
(2-tert-butylcyclohexyl) acetate;
(E)-1-ethoxy-4-(2-methylbutan-2-yl)cyclohexane;
1,1-dimethoxynon-2-yne; [essential oil];
2-cyclohexylidene-2-phenylacetonitrile;
2-cyclohexyl-1,6-heptadien-3-one; 4-cyclohexyl-2-methylbutan-2-ol;
2-phenylethyl 2-phenylacetate; (2E, 5E/Z)-5,6,7-trimethyl
octa-2,5-dien-4-one;
1-methyl-3-(4-methylpent-3-enyl)cyclohex-3-ene-1-carbaldehyde;
methyl 2,2-dimethyl-6-methylidenecyclohexane-1-carboxylate;
1-(3,3-dimethylcyclohexyl)ethyl acetate;
4-methyl-2-(2-methylprop-1-enyl)oxane;
1-spiro(4.5)-7-decen-7-yl-4-penten-1-one;
4-(2-butenylidene)-3,5,5-trimethylcyclohex-2-en-1-one;
2-(4-methyl-1-cyclohex-3-enyl)propan-2-ol;
4-isopropylidene-1-methyl-cyclohexene;
2-(4-methyl-1-cyclohex-3-enyl)propan-2-yl acetate;
3,7-dimethyloctan-3-ol; 3,7-dimethyloctan-3-ol;
3,7-dimethyloctan-3-yl acetate; 3-phenylbutanal;
(2,5-dimethyl-4-oxofuran-3-yl) acetate; 4-methyl-3-decen-5-ol;
undec-10-enal; (4-formyl-2-methoxyphenyl) 2-methylpropanoate;
2,2,5-trimethyl-5-pentylcyclopentan-1-one;
2-tert-butylcyclohexan-1-ol; (2-tert-butylcyclohexyl) acetate;
4-tert-butylcyclohexyl acetate;
1-(3-methyl-7-propan-2-yl-6-bicyclo[2.2.2]oct-3-enyl)ethanone;
(4,8-dimethyl-2-propan-2-ylidene-3,3a,4,5,6,8a-hexahydro-1H-azulen-6-yl)
acetate; [(4Z)-1-cyclooct-4-enyl] methyl carbonate; methyl beta
naphtyl ether; materials and stereoisomers thereof.
[0085] The compositions may also include a parent fragrance and one
or more encapsulated fragrances that may or may not differ from the
parent fragrance. For example, the composition may include a parent
fragrance and a non-parent fragrance. A parent fragrance refers to
a fragrance that is dispersed throughout the composition and is
typically not encapsulated when added to the composition. Herein, a
non-parent fragrance refers to a fragrance that differs from a
parent fragrance included within the composition and is
encapsulated with an encapsulating material prior to inclusion into
the composition. Non-limiting examples of differences between a
fragrance and a non-parent fragrance include differences in
chemical make-up. In some examples, dried microcapsules may be
incorporated into the composition, prepared by spray drying, fluid
bed drying, tray drying, or other such drying processes that are
available.
Suspending Agents
[0086] The compositions described herein may include one or more
suspending agents to suspend the microcapsules and other
water-insoluble material dispersed in the composition. The
concentration of the suspending agent may range from about 0.01% to
about 90%, alternatively from about 0.01% to 15% by weight of the
composition.
[0087] Non-limiting examples of suspending agents include anionic
polymers, cationic polymers, and nonionic polymers. Non-limiting
examples of said polymers include vinyl polymers such as cross
linked acrylic acid polymers with the CTFA name Carbomer, cellulose
derivatives and modified cellulose polymers such as methyl
cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl
methyl cellulose, nitro cellulose, sodium cellulose sulfate, sodium
carboxymethyl cellulose, crystalline cellulose, cellulose powder,
polyvinylpyrrolidone, polyvinyl alcohol, guar gum, hydroxypropyl
guar gum, xanthan gum, arabia gum, tragacanth, galactan, carob gum,
guar gum, karaya gum, carrageenan, pectin, agar, quince seed
(Cydonia oblonga Mill), starch (rice, corn, potato, wheat), algae
colloids (algae extract), microbiological polymers such as dextran,
succinoglucan, pulleran, starch-based polymers such as
carboxymethyl starch, methylhydroxypropyl starch, alginic
acid-based polymers such as sodium alginate and alginic acid,
propylene glycol esters, acrylate polymers such as sodium
polyacrylate, polyethylacrylate, polyacrylamide, and
polyethyleneimine, and inorganic water soluble material such as
bentonite, aluminum magnesium silicate, laponite, hectonite, and
anhydrous silicic acid. Other suspending agents may include, but
are not limited to, Konjac, Gellan, and a methyl vinyl ether/maleic
anhydride copolymer crosslinked with decadiene (e.g.
Stabileze.RTM.).
[0088] Other non-limiting examples of suspending agents include
cross-linked polyacrylate polymers like Carbomers with the trade
names Carbopol.RTM. 934, Carbopol.RTM. 940, Carbopol.RTM. 950,
Carbopol.RTM. 980, Carbopol.RTM. 981, Carbopol.RTM. Ultrez 10,
Carbopol.RTM. Ultrez 20, Carbopol.RTM. Ultrez 21, Carbopol.RTM.
Ultrez 30, Carbopol.RTM. ETD2020, Carbopol.RTM. ETD2050,
Pemulen.RTM. TR-1, and Pemulen.RTM. TR-2, available from The
Lubrizol Corporation; acrylates/steareth-20 methacrylate copolymer
with trade name ACRYSOL.TM. 22 available from Rohm and Hass;
acrylates/beheneth-25 methacrylate copolymers, trade names
including Aculyn-28 available from Rohm and Hass, and Volarest.TM.
FL available from Croda; nonoxynyl hydroxyethylcellulose with the
trade name Amercell.TM. POLYMER HM-1500 available from Amerchol;
methylcellulose with the trade name BENECEL.RTM., hydroxyethyl
cellulose with the trade name NATROSOL.RTM.; hydroxypropyl
cellulose with the trade name KLUCEL.RTM.; cetyl hydroxyethyl
cellulose with the trade name POLYSURF.RTM. 67, supplied by
Hercules; ethylene oxide and/or propylene oxide based polymers with
the trade names CARBOWAX.RTM. PEGs, POLYOX WASRs, and UCON.RTM.
FLUIDS, all supplied by Amerchol; ammonium acryloyl
dimethyltaurate/carboxyethyl-acrylate-crosspolymers like
Aristoflex.RTM. TAC copolymer, ammonium acryloyl dimethyltaurate/VP
copolymers like Aristoflex.RTM. AVS copolymer, sodium acryloyl
dimethyltaurate/VP crosspolymers like Aristoflex.RTM. AVS
copolymer, ammonium acryloyl dimethyltaurate/beheneth-25
methacrylate crosspolymers like Aristoflex.RTM. BVL or HMB, all
available from Clariant Corporation; polyacrylate crosspolymer-6
with the trade name Sepimax.TM. Zen, available from Seppic; and
cross-linked copolymers of vinyl pyrrolidone and acrylic acid such
as UltraThix.TM. P-100 polymer available from Ashland.
[0089] Other non-limiting examples of suspending agents include
crystalline suspending agents which can be categorized as acyl
derivatives, long chain amine oxides, and mixtures thereof.
[0090] Other non-limiting examples of suspending agents include
ethylene glycol esters of fatty acids, in some aspects those having
from about 16 to about 22 carbon atoms; ethylene glycol stearates,
both mono and distearate, in some aspects, the distearate
containing less than about 7% of the mono stearate; alkanol amides
of fatty acids, having from about 16 to about 22 carbon atoms, or
about 16 to 18 carbon atoms, examples of which include stearic
monoethanolamide, stearic diethanolamide, stearic
monoisopropanolamide and stearic monoethanolamide stearate; long
chain acyl derivatives including long chain esters of long chain
fatty acids (e.g., stearyl stearate, cetyl palmitate, etc.); long
chain esters of long chain alkanol amides (e.g., stearamide
diethanolamide distearate, stearamide monoethanolamide stearate);
and glyceryl esters (e.g., glyceryl distearate, trihydroxystearin,
tribehenin), a commercial example of which is Thixin.RTM. R
available from Rheox, Inc. Other non-limiting examples of
suspending agents include long chain acyl derivatives, ethylene
glycol esters of long chain carboxylic acids, long chain amine
oxides, and alkanol amides of long chain carboxylic acids.
[0091] Other non-limiting examples of suspending agents include
long chain acyl derivatives including N,N-dihydrocarbyl amido
benzoic acid and soluble salts thereof (e.g., Na, K), particularly
N,N-di(hydrogenated) C.sub.16, C.sub.18 and tallow amido benzoic
acid species of this family, which are commercially available from
Stepan Company (Northfield, Ill., USA).
[0092] Non-limiting examples of suitable long chain amine oxides
for use as suspending agents include alkyl dimethyl amine oxides
(e.g., stearyl dimethyl amine oxide).
[0093] Other non-limiting suitable suspending agents include
primary amines having a fatty alkyl moiety having at least about 16
carbon atoms, examples of which include palmitamine or stearamine,
and secondary amines having two fatty alkyl moieties each having at
least about 12 carbon atoms, examples of which include
dipalmitoylamine or di(hydrogenated tallow)amine. Other
non-limiting examples of suspending agents include di(hydrogenated
tallow)phthalic acid amide, and cross-linked maleic
anhydride-methyl vinyl ether copolymer.
Coloring Agents
[0094] The compositions herein may include a coloring agent. A
coloring agent may be in the form of a pigment. As used herein, the
term "pigment" means a solid that reflects light of certain
wavelengths while absorbing light of other wavelengths, without
providing appreciable luminescence. Useful pigments include, but
are not limited to, those which are extended onto inert mineral(s)
(e.g., talk, calcium carbonate, clay) or treated with silicone or
other coatings (e.g., to prevent pigment particles from
re-agglomerating or to change the polarity (hydrophobicity) of the
pigment. Pigments may be used to impart opacity and color. Any
pigment that is generally recognized as safe (such as those listed
in C.T.F.A. cosmetic Ingredient Handbook, 3.sup.rd Ed., cosmetic
and Fragrance Association, Inc., Washington, D.C. (1982), herein
incorporated by reference) may be included in the compositions
described herein. Non-limiting examples of pigments include body
pigment, inorganic white pigment, inorganic colored pigment,
pearling agent, and the like. Non-limiting examples of pigments
include talc, mica, magnesium carbonate, calcium carbonate,
magnesium silicate, aluminum magnesium silicate, silica, titanium
dioxide, zinc oxide, red iron oxide, yellow iron oxide, black iron
oxide, ultramarine, polyethylene powder, methacrylate powder,
polystyrene powder, silk powder, crystalline cellulose, starch,
titanated mica, iron oxide titanated mica, bismuth oxychloride, and
the like. The aforementioned pigments can be used independently or
in combination.
[0095] Other non-limiting examples of pigments include inorganic
powders such as gums, chalk, Fuller's earth, kaolin, sericite,
muscovite, phlogopite, synthetic mica, lepidolite, biotite, lithia
mica, vermiculite, aluminum silicate, starch, smectite clays, alkyl
and/or trialkyl aryl ammonium smectites, chemically modified
magnesium aluminum silicate, organically modified montmorillonite
clay, hydrated aluminum silicate, fumed aluminum starch octenyl
succinate barium silicate, calcium silicate, magnesium silicate,
strontium silicate, metal tungstate, magnesium, silica alumina,
zeolite, barium sulfate, calcined calcium sulfate (calcined
gypsum), calcium phosphate, fluorine apatite, hydroxyapatite,
ceramic powder, metallic soap (zinc stearate, magnesium stearate,
zinc myristate, calcium palmitate, and aluminum stearate),
colloidal silicone dioxide, and boron nitride; organic powder such
as polyamide resin powder (nylon powder), cyclodextrin, methyl
polymethacrylate powder, copolymer powder of styrene and acrylic
acid, benzoguanamine resin powder, poly(ethylene tetrafluoride)
powder, and carboxyvinyl polymer, cellulose powder such as
hydroxyethyl cellulose and sodium carboxymethyl cellulose, ethylene
glycol monostearate; inorganic white pigments such as magnesium
oxide. Non-limiting examples of pigments include nanocolorants from
BASF and multi-layer interference pigments such as Sicopearls from
BASF. The pigments may be surface treated to provide added
stability of color and ease of formulation. Non-limiting examples
of pigments include aluminum, barium or calcium salts or lakes.
Some other non-limiting examples of coloring agents include Red 3
Aluminum Lake, Red 21 Aluminum Lake, Red 27 Aluminum Lake, Red 28
Aluminum Lake, Red 33 Aluminum Lake, Yellow 5 Aluminum Lake, Yellow
6 Aluminum Lake, Yellow 10 Aluminum Lake, Orange 5 Aluminum Lake
and Blue 1 Aluminum Lake, Red 6 Barium Lake, Red 7 Calcium
Lake.
[0096] A coloring agent may also be a dye. Non-limiting examples
include Red 6, Red 21, Brown, Russet and Sienna dyes, Yellow 5,
Yellow 6, Red 33, Red 4, Blue 1, Violet 2, and mixtures thereof.
Other non-limiting examples of dyes include fluorescent dyes like
fluorescein.
Other Ingredients
[0097] The compositions may include other ingredients like
antioxidants, ultraviolet inhibitors like sunscreen agents and
physical sunblocks, cyclodextrins, quenchers, and/or skin care
actives. Non-limiting examples of other ingredients include
2-ethylhexyl-p-methoxycinnamate; hexyl
2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate;
4-tert-butyl-4'-methoxy dibenzoylmethane;
2-hydroxy-4-methoxybenzo-phenone; 2-phenylbenzimidazole-5-sulfonic
acid; octocrylene; zinc oxide; titanium dioxide; vitamins like
vitamin C, vitamin B, vitamin A, vitamin E, and derivatives
thereof; flavones and flavonoids; amino acids like glycine,
tyrosine, etc.; carotenoids and carotenes; chelating agents like
EDTA, lactates, citrates, and derivatives thereof.
First and Second Compositions
[0098] The dispenser may include a first composition stored in a
first receptacle and a second composition stored in the second
receptacle. The first composition may include a volatile solvent
and a first fragrance. The second composition may include a
plurality of microcapsules and a carrier (e.g. water). The second
composition my further include a suspending agent. The first and
second compositions may each further include any other ingredient
listed herein unless such an ingredient negatively affects the
performance of the microcapsules. Non-limiting examples of other
ingredients include a coloring agent included in at least one of
the first and second compositions and at least one non-encapsulated
fragrance in the first composition or second composition. When the
second composition comprises microcapsules encapsulating a
fragrance, the second compositions may further include a
non-encapsulated fragrance that may or may not differ from the
encapsulated fragrance in chemical make-up. In some examples, the
second composition may be substantially free of a material selected
from the group consisting of a propellant, ethanol, a detersive
surfactant, and combinations thereof; preferably free of a material
selected from the group consisting of a propellant, ethanol, a
detersive surfactant, and combinations thereof. Non-limiting
examples of propellants include compressed air, nitrogen, inert
gases, carbon dioxide, gaseous hydrocarbons like propane, n-butane,
isobutene, cyclopropane, and mixtures thereof. In some examples,
the first composition may be substantially free of a material
selected from the group consisting of a propellant, microcapsules,
a detersive surfactant, and combinations thereof; preferably free
of a material selected from the group consisting of propellant,
microcapsules, a detersive surfactant, and combinations thereof. At
least some of the microcapsules included in such a dispenser may
encapsulate a fragrance. The fragrance encapsulated within the
microcapsules may or may not differ in chemical make-up from the
non-encapsulated fragrance included with the volatile solvent.
[0099] In some examples, the second composition may include at
least 50%, at least 75%, or even at least 90%, by weight of the
composition, of water; a plurality of microcapsules; and from about
0.01% to about 90%, preferably from about 0.01% to about 15%, more
preferably from about 0.5% to about 15%, by weight of the
composition, of a suspending agent; wherein the composition is free
of propellants, volatile solvents (e.g. ethanol), and detersive
surfactants; wherein the microcapsules comprise a first fragrance
and a shell that surrounds said first fragrance. In some examples,
the second composition may be substantially free of, or
alternatively, free of a wax, an antiperspirant, and combinations
thereof. In some examples, the second composition may comprise
about 20% or less, about 10% or less, about 7% or less, of the
microcapsules. It is to be appreciated that because the second
composition is to be atomized, the concentration of the
microcapsules in the second composition should not be so high as to
prevent suitable atomization.
Method of Use
[0100] The compositions disclosed herein may be applied to one or
more skin surfaces and/or one or more mammalian keratinous tissue
surfaces as part of a user's daily routine or regimen. Additionally
or alternatively, the compositions herein may be used on an "as
needed" basis. The compositions may be applied to any article, such
as a textile, or any absorbent article including, but not limited
to, feminine hygiene articles, diapers, and adult incontinence
articles. For example, while the combinations of the dispensers,
assemblies, and compositions described herein are exquisitely
designed to be used as a fine fragrance spray, it is understood
that such combinations may also be used as a body spray, feminine
spray, adult incontinence spray, baby spray, or other spray. The
size, shape, and aesthetic design of the dual dispensers described
herein may vary widely.
Test Methods
[0101] It is understood that the test methods that are disclosed in
the Test Methods Section of the present application should be used
to determine the respective values of the parameters of Applicants'
invention as such invention is described and claimed herein.
(1) Fracture Strength
[0102] a.) Place 1 gram of particles in 1 liter of distilled
deionized (DI) water. [0103] b.) Permit the particles to remain in
the DI water for 10 minutes and then recover the particles by
filtration. [0104] c.) Determine the average rupture force of the
particles by averaging the rupture force of 50 individual
particles. The rupture force of a particle is determined using the
procedure given in Zhang, Z.; Sun, G; "Mechanical Properties of
Melamine-Formaldehyde microcapsules," J. Microencapsulation, vol
18, no. 5, pages 593-602, 2001. Then calculate the average fracture
strength by dividing the average rupture force (in Newtons) by the
average cross-sectional area of the spherical particle
(.pi.r.sup.2, where r is the radius of the particle before
compression), said average cross-sectional area being determined as
follows: [0105] (i) Place 1 gram of particles in 1 liter of
distilled deionized (DI) water. [0106] (ii) Permit the particles to
remain in the DI water for 10 minutes and then recover the
particles by filtration. [0107] (iii) Determine the particle size
distribution of the particle sample by measuring the particle size
of 50 individual particles using the experimental apparatus and
method of Zhang, Z.; Sun, G; "Mechanical Properties of
MelamineFormaldehyde microcapsules," J. Microencapsulation, vol 18,
no. 5, pages 593-602, 2001. [0108] (iv) Average the 50 independent
particle diameter measurements to obtain an o average particle
diameter. [0109] d.) For a capsule slurry, the sample is divided
into three particle size fractions covering the particle size
distribution. Per particle size fraction about 30 fracture
strengths are determined.
(2) ClogP
[0110] The "calculated logP" (ClogP) is determined by the fragment
approach of Hansch and Leo (cf., A. Leo, in Comprehensive Medicinal
Chemistry, Vol. 4, C. Hansch, P. G. Sammens, J. B. Taylor, and c.
A. Ramsden, Eds. P. 295, Pergamon Press, 1990, incorporated herein
by reference). ClogP values may be calculated by using the "CLOGP"
program available from Daylight Chemical Information Systems Inc.
of Irvine, Calif. U.S.A.
(3) Boiling Point
[0111] Boiling point is measured by ASTM method D2887-04a,
"Standard Test Method for Boiling Range Distribution of Petroleum
Fractions by Gas Chromatography," ASTM International.
(4) Volume Weight Fractions
[0112] Volume weight fractions are determined via the method of
single-particle optical sensing (SPOS), also called optical
particle counting (OPC). Volume weight fractions are determined via
an Accusizer 780/AD supplied by Particle Sizing Systems of Santa
Barbara Calif. U.S.A. or equivalent.
Procedure:
[0113] 1) Put the sensor in a cold state by flushing water through
the sensor; [0114] 2) Confirm background counts are less than 100
(if more than 100, continue the flush) [0115] 3) Prepare particle
standard: pipette approx. 1 ml of shaken particles into a blender
filled with approx. 2 cups of DI water. Blend it. Pipette approx. 1
ml of diluted, blended particles into 50 ml of DI water. [0116] 4)
Measure particle standard: pipette approx. 1 ml of double diluted
standard into Accusizer bulb. Press the start
measurement-Autodilution button. Confirm particles counts are more
than 9200 by looking in the status bar. If counts are less than
9200, press stop and 10 inject more sample. [0117] 5) Immediately
after measurement, inject one full pipette of soap (5% Micro 90)
into bulb and press the Start Automatic Flush Cycles button.
(5) Volume Weighted Fracture Strength (VWFS)
[0118] VWFS=(fracture strength.sub.1.times.volume
fraction.sub.1)+(fracture strength.sub.2.times.volume
fraction.sub.2)+(fracture strength.sub.3.times.volume
fraction.sub.3) [0119] Fracture strength.sub.1=average fracture
strength measured from a pool of 10 microcapsules (with similar
particle size) [0120] Volume fraction.sub.1=volume fraction
determined via Accusizer of particle distribution corresponding to
fracture strength.sub.1
[0121] The spread around the fracture strength to determine the
volume fraction is determined as follows:
[0122] For particle batches with a mean particle sizes of about 15
micrometers a spread of about 10 micrometers is used, for particle
batches with a mean particle sizes of about 30 micrometers and
above, a spread of about 10 to 15 micrometers is used.
TABLE-US-00001 Mean Fracture Strength Volume Particle Particle
Determination at Volume Fracture Batch Size 3 particle sizes
Fractions Strength Melamine- 31 21 micron, 1.8 1 to 25 microns, 1.5
MPa based microns MPa; 31 micron, 30%; 25 to 36 polyurea 1.6 MPa;
41 microns, 40%; micron, 1.2 MPa) 36 to 50 microns, 30%
(6) Benefit Agent Leakage Test
[0123] a.) Obtain 2, one gram samples of benefit agent particle
composition. [0124] b.) Add 1 gram (Sample 1) of particle
composition to 99 grams of product matrix that the particle will be
employed in and with the second sample immediately proceed to Step
d below. [0125] c.) Age the particle containing product matrix
(Sample 1) of a.) above for 2 weeks at 35.degree. C. in a sealed,
glass jar. [0126] d.) Recover the particle composition's particles
from the product matrix of c.) (Sample 1 in product matrix) and
from particle composition (Sample 2) above by filtration. [0127]
e.) Treat each particle sample from d.) above with a solvent that
will extract all the benefit agent from each samples' particles.
[0128] f.) Inject the benefit agent containing solvent from each
sample from e.) above into a Gas Chromatograph and integrate the
peak areas to determine the total quantity of benefit agent
extracted from each sample. [0129] g.) The benefit agent leakage is
defined as: [0130] Value from f.) above for Sample 2--Value from
f.) above for Sample 1.
(7) Test Method for Determining Median Volume-Weighted Particle
Size of Microcapsules
[0131] One skilled in the art will recognize that various protocols
may be constructed for the extraction and isolation of
microcapsules from finished products, and will recognize that such
methods require validation via a comparison of the resulting
measured values, as measured before and after the microcapsules'
addition to and extraction from the finished product. The isolated
microcapsules are then formulated in deionized water to form a
capsule slurry for characterization for particle size
distribution.
[0132] The median volume-weighted particle size of the
microcapsules is measured using an Accusizer 780A, made by Particle
Sizing Systems, Santa Barbara Calif., or equivalent. The instrument
is calibrated from 0 to 300 .mu.m using particle size standards (as
available from Duke/Thermo-Fisher-Scientific Inc., Waltham, Mass.,
USA). Samples for particle size evaluation are prepared by diluting
about 1 g of capsule slurry in about 5 g of de-ionized water and
further diluting about 1 g of this solution in about 25 g of water.
About 1 g of the most dilute sample is added to the Accusizer and
the testing initiated using the autodilution feature. The Accusizer
should be reading in excess of 9200 counts/second. If the counts
are less than 9200 additional sample should be added. Dilute the
test sample until 9200 counts/second and then the evaluation should
be initiated. After 2 minutes of testing the Accusizer will display
the results, including the median volume-weighted particle
size.
EXAMPLES
[0133] The following examples are given solely for the purpose of
illustration and are not to be construed as limiting the invention,
as many variations thereof are possible.
[0134] In the examples, all concentrations are listed as weight
percent, unless otherwise specified and may exclude minor materials
such as diluents, filler, and so forth. The listed formulations,
therefore, comprise the listed components and any minor materials
associated with such components. As is apparent to one of ordinary
skill in the art, the selection of these minor materials will vary
depending on the physical and chemical characteristics of the
particular ingredients selected to make the present invention as
described herein.
Example 1
Polyacrylate Microcapsule
[0135] An oil solution, consisting of 128.4 g Fragrance Oil, 32.1 g
isopropyl myristate, 0.86 g DuPont Vazo-67, 0.69 g Wako Chemicals
V-501, is added to a 35.degree. C. temperature controlled steel
jacketed reactor, with mixing at 1000 rpm (4 tip, 2'' diameter,
flat mill blade) and a nitrogen blanket applied at 100 cc/min. The
oil solution is heated to 70.degree. C. in 45 minutes, held at
75.degree. C. for 45 minutes, and cooled to 50.degree. C. in 75
minutes. This will be called oil solution A.
[0136] In a reactor vessel, an aqueous solution is prepared
consisting of 300 g deionized water to which is dispersed 2.40
grams of Celvol 540 polyvinyl alcohol at 25 degrees Centigrade. The
mixture is heated to 85 degrees Centigrade and held there for 45
minutes. The solution is cooled to 30 degrees Centigrade. 1.03
grams of Wako Chemicals V-501 initiator is added, along with 0.51
grams of 40% sodium hydroxide solution. Heat the solution to
50.degree. C., and maintain the solution at that temperature.
[0137] To the oil solution A, add 0.19 grams of tert-butyl amino
ethyl methacrylate (Sigma Aldrich), 0.19 grams of beta-carboxy
ethyl acrylate (Sigma Aldrich), and 15.41 grams of Sartomer CN975
(Sartomer, Inc.). Mix the acrylate monomers into the oil phase for
10 minutes. This will be called oil solution B. Use a Caframo mixer
with a 4-blade pitched turbine agitator.
[0138] Start nitrogen blanket on top of the aqueous solution in
reactor. Start transferring the oil solution B into the aqueous
solution in the reactor, with minimal mixing. Increase mixing to
1800-2500 rpm, for 60 minutes to emulsify the oil phase into the
water solution. After milling is completed, mixing is continued
with a 3'' propeller at 350 rpm. The batch is held at 50.degree. C.
for 45 minutes, the temperature is increased to 75.degree. C. in 30
minutes, held at 75.degree. C. for 4 hours, heated to 95.degree. C.
in 30 minutes and held at 95.degree. C. for 6 hours. The batch is
then allowed to cool to room temperature.
[0139] The resultant microcapsules have a median particle size of
12.6 microns, a fracture strength of 7.68.+-.2.0 MPa, and a
51%.+-.20% deformation at fracture.
Example 2
Polyacrylate Microcapsules
[0140] An oil solution, consisting of 96 g Fragrance Oil, 64 g
isopropyl myristate, 0.86 g DuPont Vazo-67, 0.69 g Wako Chemicals
V-501, is added to a 35.degree. C. temperature controlled steel
jacketed reactor, with mixing at 1000 rpm (4 tip, 2'' diameter,
flat mill blade) and a nitrogen blanket applied at 100 cc/min. The
oil solution is heated to 70.degree. C. in 45 minutes, held at
75.degree. C. for 45 minutes, and cooled to 50.degree. C. in 75
minutes. This will be called oil solution A.
[0141] In a reactor vessel, an aqueous solution is prepared
consisting of 300 g deionized water to which is dispersed 2.40
grams of Celvol 540 polyvinyl alcohol at 25 degrees Centigrade. The
mixture is heated to 85 degrees Centigrade and held there for 45
minutes. The solution is cooled to 30 degrees Centigrade. 1.03
grams of Wako Chemicals V-501 initiator is added, along with 0.51
grams of 40% sodium hydroxide solution. Heat the solution to
50.degree. C., and maintain the solution at that temperature.
[0142] To the oil solution A, add 0.19 grams of tert-butyl amino
ethyl methacrylate (Sigma Aldrich), 0.19 grams of beta-carboxy
ethyl acrylate (Sigma Aldrich), and 15.41 grams of Sartomer CN975
(Sartomer, Inc.). Mix the acrylate monomers into the oil phase for
10 minutes. This will be called oil solution B. Use a Caframo mixer
with a 4-blade pitched turbine agitator.
[0143] Start nitrogen blanket on top of the aqueous solution in
reactor. Start transferring the oil solution B into the aqueous
solution in the reactor, with minimal mixing. Increase mixing to
1800-2500 rpm, for 60 minutes to emulsify the oil phase into the
water solution. After milling is completed, mixing is continued
with a 3'' propeller at 350 rpm. The batch is held at 50.degree. C.
for 45 minutes, the temperature is increased to 75.degree. C. in 30
minutes, held at 75.degree. C. for 4 hours, heated to 95.degree. C.
in 30 minutes and held at 95.degree. C. for 6 hours. The batch is
then allowed to cool to room temperature.
[0144] The resultant microcapsules have a median particle size of
12.6 microns, a fracture strength of 2.60.+-.1.2 MPa, 37%.+-.15%
deformation at fracture.
Example 3
Polyacrylate Microcapsules
[0145] An oil solution, consisting of 128.4 g Fragrance Oil, 32.1 g
isopropyl myristate, 0.86 g DuPont Vazo-67, 0.69 g Wako Chemicals
V-501, is added to a 35.degree. C. temperature controlled steel
jacketed reactor, with mixing at 1000 rpm (4 tip, 2'' diameter,
flat mill blade) and a nitrogen blanket applied at 100 cc/min. The
oil solution is heated to 70.degree. C. in 45 minutes, held at
75.degree. C. for 45 minutes, and cooled to 50.degree. C. in 75
minutes. This will be called oil solution A.
[0146] In a reactor vessel, an aqueous solution is prepared
consisting of 300 g deionized water to which is dispersed 2.40
grams of Celvol 540 polyvinyl alcohol at 25 degrees Centigrade. The
mixture is heated to 85 degrees Centigrade and held there for 45
minutes. The solution is cooled to 30 degrees Centigrade. 1.03
grams of Wako Chemicals V-501 initiator is added, along with 0.51
grams of 40% sodium hydroxide solution. Heat the solution to
50.degree. C., and maintain the solution at that temperature.
[0147] To the oil solution A, add 0.19 grams of tert-butyl amino
ethyl methacrylate (Sigma Aldrich), 0.19 grams of beta-carboxy
ethyl acrylate (Sigma Aldrich), and 15.41 grams of Sartomer CN975
(Sartomer, Inc.). Mix the acrylate monomers into the oil phase for
10 minutes. This will be called oil solution B. Use a Caframo mixer
with a 4-blade pitched turbine agitator.
[0148] Start nitrogen blanket on top of the aqueous solution in
reactor. Start transferring the oil solution B into the aqueous
solution in the reactor, with minimal mixing. Increase mixing to
1300-1600 rpm, for 60 minutes to emulsify the oil phase into the
water solution. After milling is completed, mixing is continued
with a 3'' propeller at 350 rpm. The batch is held at 50.degree. C.
for 45 minutes, the temperature is increased to 75.degree. C. in 30
minutes, held at 75.degree. C. for 4 hours, heated to 95.degree. C.
in 30 minutes and held at 95.degree. C. for 6 hours. The batch is
then allowed to cool to room temperature.
[0149] The resultant microcapsules have a median particle size of
26.1 microns, a fracture strength of 1.94.+-.1.2 MPa, 30%.+-.14%
deformation at fracture.
Example 4
Polyacrylate Microcapsules
[0150] An oil solution, consisting of 128.4 g Fragrance Oil, 32.1 g
isopropyl myristate, 0.86 g DuPont Vazo-67, 0.69 g Wako Chemicals
V-501, is added to a 35.degree. C. temperature controlled steel
jacketed reactor, with mixing at 1000 rpm (4 tip, 2'' diameter,
flat mill blade) and a nitrogen blanket applied at 100 cc/min. The
oil solution is heated to 70.degree. C. in 45 minutes, held at
75.degree. C. for 45 minutes, and cooled to 50.degree. C. in 75
minutes. This will be called oil solution A.
[0151] In a reactor vessel, an aqueous solution is prepared
consisting of 300 g deionized water to which is dispersed 2.40
grams of Celvol 540 polyvinyl alcohol at 25 degrees Centigrade. The
mixture is heated to 85 degrees Centigrade and held there for 45
minutes. The solution is cooled to 30 degrees Centigrade. 1.03
grams of Wako Chemicals V-501 initiator is added, along with 0.51
grams of 40% sodium hydroxide solution. Heat the solution to
50.degree. C., and maintain the solution at that temperature.
[0152] To the oil solution A, add 0.19 grams of tert-butyl amino
ethyl methacrylate (Sigma Aldrich), 0.19 grams of beta-carboxy
ethyl acrylate (Sigma Aldrich), and 15.41 grams of Sartomer CN975
(Sartomer, Inc.). Mix the acrylate monomers into the oil phase for
10 minutes. This will be called oil solution B. Use a Caframo mixer
with a 4-blade pitched turbine agitator.
[0153] Start nitrogen blanket on top of the aqueous solution in
reactor. Start transferring the oil solution B into the aqueous
solution in the reactor, with minimal mixing. Increase mixing to
2500-2800 rpm, for 60 minutes to emulsify the oil phase into the
water solution. After milling is completed, mixing is continued
with a 3'' propeller at 350 rpm. The batch is held at 50.degree. C.
for 45 minutes, the temperature is increased to 75.degree. C. in 30
minutes, held at 75.degree. C. for 4 hours, heated to 95.degree. C.
in 30 minutes and held at 95.degree. C. for 6 hours. The batch is
then allowed to cool to room temperature.
[0154] The resultant microcapsules have a median particle size of
10.0 microns, a fracture strength of 7.64.+-.2.2 MPa, 56%.+-.20%
deformation at fracture.
Example 5
Polyurea/urethane Microcapsules
[0155] An aqueous solution, consisting of 6.06 g Celvol 523
polyvinyl alcohol (Celanese Chemicals) and 193.94 g deionized
water, is added into a temperature controlled steel jacketed
reactor at room temperature. Then an oil solution, consisting of 75
g Scent A and 25 g Desmodur N3400 (polymeric hexamethylene
diisocyanate), is added into the reactor. The mixture is emulsified
with a propeller (4 tip, 2'' diameter, flat mill blade; 2200 rpm)
to desired emulsion droplet size. The resulting emulsion is then
mixed with a Z-bar propeller at 450 rpm. An aqueous solution,
consisting of 47 g water and 2.68 g tetraethylenepentamine, is
added into the emulsion. And it is then heated to 60.degree. C.,
held at 60.degree. C. for 8 hours, and allowed to cool to room
temperature. The median particle size of the resultant
microcapsules is 10 microns.
Example 6
Polyurea/urethane Microcapsules
[0156] Prepare the Oil Phase by adding 4.44 grams of isophorone
diisocyanate (Sigma Aldrich) to 5.69 grams of Scent A fragrance
oil. Prepare a Water Phase by mixing 1.67 grams of Ethylene Diamine
(Sigma Aldrich) and 0.04 grams of 1,4-Diazabicyclo[2.2.2]octane
(Sigma Aldrich) into 40 grams of a 5 wt % aqueous solution of
Polyvinylpyrrolidone K-90 (Sigma Aldrich) at 10 degrees Centigrade.
Next, add the Oil Phase contents to 15.0 grams of a 5 wt % aqueous
solution of Polyvinylpyrrolidone K-90 (Sigma Aldrich), while
agitating the mix at 1400 RPM using a Janke & Kunkel IKA
Laboretechnik RW20 DZM motor with a 3-blade turbine agitator for
approximately 9 minutes. Next, add the addition of the Water Phase
into the emulsified Oil Phase dropwise over a 6.5 minute period,
while continuing to agitate at 1400 RPM. Continue to agitate for 23
minutes, then reduce the agitation speed to 1000 RPM. After 3.75
additional hours, reduce the agitation speed to 500 RPM, and
continue to agitate for 14 hours. Start heating the dispersion to
50 degrees Centigrade, over a 2 hour period. Age the capsules at 50
C for 2 hours, then collect the microcapsules. The resultant
microcapsules have a median particle size of 12 microns.
Example 7
Polyacrylate Microcapsules
[0157] The polyacrylate microcapsule with the characteristics
displayed in Table 3 may be prepared as follows. An oil solution,
consisting of 112.34 g Fragrance Oil, 12.46 g isopropyl myristate,
2.57 g DuPont Vazo-67, 2.06 g Wako Chemicals V-501, is added to a
35.degree. C. temperature controlled steel jacketed reactor, with
mixing at 1000 rpm (4 tip, 2'' diameter, flat mill blade) and a
nitrogen blanket applied at 100 cc/min. The oil solution is heated
to 70.degree. C. in 45 minutes, held at 75.degree. C. for 45
minutes, and cooled to 50.degree. C. in 75 minutes. This will be
called oil solution A.
[0158] In a reactor vessel, an aqueous solution is prepared
consisting of 300 g deionized water to which is dispersed 2.40
grams of Celvol 540 polyvinyl alcohol at 25 degrees Centigrade. The
mixture is heated to 85 degrees Centigrade and held there for 45
minutes. The solution is cooled to 30 degrees Centigrade. 1.03
grams of Wako Chemicals V-501 initiator is added, along with 0.51
grams of 40% sodium hydroxide solution. Heat the solution to
50.degree. C., and maintain the solution at that temperature.
[0159] To the oil solution A, add 0.56 grams of tert-butyl amino
ethyl methacrylate (Sigma Aldrich), 0.56 grams of beta-carboxy
ethyl acrylate (Sigma Aldrich), and 46.23 grams of Sartomer CN975
(Sartomer, Inc.). Mix the acrylate monomers into the oil phase for
10 minutes. This will be called oil solution B. Use a Caframo mixer
with a 4-blade pitched turbine agitator.
[0160] Start nitrogen blanket on top of the aqueous solution in
reactor. Start transferring the oil solution B into the aqueous
solution in the reactor, with minimal mixing. Increase mixing to
1800-2500 rpm, for 60 minutes to emulsify the oil phase into the
water solution. After milling is completed, mixing is continued
with a 3'' propeller at 350 rpm. The batch is held at 50.degree. C.
for 45 minutes, the temperature is increased to 75.degree. C. in 30
minutes, held at 75.degree. C. for 4 hours, heated to 95.degree. C.
in 30 minutes and held at 95.degree. C. for 6 hours. The batch is
then allowed to cool to room temperature.
Example 8
Spray Drying of Perfume Microcapsules
[0161] The microcapsules of Example 1 are pumped at a rate of 1
kg/hr into a co-current spray dryer (Niro Production Minor, 1.2
meter diameter) and atomized using a centrifugal wheel (100 mm
diameter) rotating at 18,000 RPM. Dryer operating conditions are:
air flow of 80 kg/hr, an inlet air temperature of 200 degrees
Centigrade, an outlet temperature of 100 degrees Centigrade, dryer
operating at a pressure of -150 millimeters of water vacuum. The
dried powder is collected at the bottom of a cyclone. The collected
microcapsules have an approximate particle diameter of 11 microns.
The equipment used the spray drying process may be obtained from
the following suppliers: IKA Werke GmbH & Co. KG, Janke and
Kunkel--Str. 10, D79219 Staufen, Germany; Niro A/S Gladsaxevej 305,
P.O. Box 45, 2860 Soeborg, Denmark and Watson-Marlow Bredel Pumps
Limited, Falmouth, Cornwall, TR11 4RU, England.
Example 9
[0162] The microcapsules described in EXAMPLES 1-8 may be used as
illustrated in the First Composition below at the indicated
percentage.
TABLE-US-00002 (% w/w) First Composition Ethanol (96%) 74.88
Fragrance 14 Water 10.82 Diethylamino Hydroxybenzol Hexyl 0.195
Benzoate Ethylhexyl Methoxycinnamate 0.105 Second Composition Water
92.5847 Microcapsules 6.0361 Carbomer 0.5018 Phenoxyethanol 0.2509
Magnesium Chloride 0.2456 Sodium Hydroxide 0.1254 Disodium EDTA
0.0836 Polyvinyl alcohol 0.0655 Sodium Benzoate 0.0409 Potassium
Sorbate 0.0409 Xanthan Gum 0.0246
[0163] It should be understood that every maximum numerical
limitation given throughout this specification includes every lower
numerical limitation, as if such lower numerical limitations were
expressly written herein. Every minimum numerical limitation given
throughout this specification will include every higher numerical
limitation, as if such higher numerical limitations were expressly
written herein. Every numerical range given throughout this
specification will include every narrower numerical range that
falls within such broader numerical range, as if such narrower
numerical ranges were all expressly written herein.
[0164] The dimensions and values disclosed herein are not to be
understood as being strictly limited to the exact numerical values
recited. Instead, unless otherwise specified, each such dimension
is intended to mean both the recited value and a functionally
equivalent range surrounding that value. For example, a dimension
disclosed as "40 mm" is intended to mean "about 40 mm."
[0165] Every document cited herein, including any cross referenced
or related patent or application and any patent application or
patent to which this application claims priority or benefit
thereof, is hereby incorporated herein by reference in its entirety
unless expressly excluded or otherwise limited. The citation of any
document is not an admission that it is prior art with respect to
any invention disclosed or claimed herein or that it alone, or in
any combination with any other reference or references, teaches,
suggests or discloses any such invention. Further, to the extent
that any meaning or definition of a term in this document conflicts
with any meaning or definition of the same term in a document
incorporated by reference, the meaning or definition assigned to
that term in this document shall govern.
[0166] While particular embodiments of the present invention have
been illustrated and described, it would be obvious to those
skilled in the art that various other changes and modifications can
be made without departing from the spirit and scope of the
invention. It is therefore intended to cover in the appended claims
all such changes and modifications that are within the scope of
this invention.
* * * * *